0001845022-23-000038 | 10-K | XBRL Viewer

Print Document View Excel Document

Cover - USD ($) $ in Millions	12 Months Ended
Cover - USD ($) $ in Millions	Jan. 31, 2023	Feb. 28, 2023	Jul. 29, 2022
Cover [Abstract]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Jan. 31, 2023
Current Fiscal Year End Date	--01-31
Document Transition Report	false
Entity File Number	001-040601
Entity Registrant Name	Couchbase, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	26-3576987
Entity Address, Address Line One	3250 Olcott Street
Entity Address, City or Town	Santa Clara
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95054
City Area Code	650
Local Phone Number	417-7500
Title of 12(b) Security	Common stock, par value $0.00001 per share
Trading Symbol	BASE
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
ICFR Auditor Attestation Flag	false
Entity Shell Company	false
Entity Public Float			$ 385.7
Entity Common Stock, Shares Outstanding		45,613,726
Documents Incorporated by Reference	Portions of the registrant’s proxy statement for the 2023 annual meeting of stockholders are incorporated herein by reference in Part III of this Annual Report on Form 10-K to the extent stated herein. Such proxy statement will be filed with the Securities and Exchange Commission within 120 days of the registrant’s fiscal year ended January 31, 2023
Entity Central Index Key	0001845022
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	FY
Amendment Flag	false

Audit Information	12 Months Ended
Audit Information	Jan. 31, 2023
Audit Information [Abstract]
Auditor Name	PricewaterhouseCoopers LLP
Auditor Firm ID	238
Auditor Location	San Jose, California

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jan. 31, 2023	Jan. 31, 2022
Current assets
Cash and cash equivalents	$ 40,446	$ 95,688
Short-term investments	127,856	110,266
Accounts receivable, net	39,847	36,696
Deferred commissions	13,096	11,783
Prepaid expenses and other current assets	8,234	8,559
Total current assets	229,479	262,992
Property and equipment, net	7,430	4,288
Operating lease right-of-use assets	6,940	0
Deferred commissions, noncurrent	7,524	8,243
Other assets	1,666	1,219
Total assets	253,039	276,742
Current liabilities
Accounts payable	1,407	1,923
Accrued compensation and benefits	12,641	16,143
Other accrued expenses	6,076	3,231
Operating lease liabilities	3,117	0
Deferred revenue	71,716	69,010
Total current liabilities	94,957	90,307
Operating lease liabilities, noncurrent	4,543	0
Deferred revenue, noncurrent	3,275	2,713
Other liabilities	0	507
Total liabilities	102,775	93,527
Commitments and contingencies (Note 9)
Stockholders’ equity (deficit)
Preferred stock, $0.00001 par value; 200,000,000 shares authorized as of January 31, 2023 and 2022; zero shares issued and outstanding as of January 31, 2023 and 2022	0	0
Common stock, $0.00001 par value; 1,000,000,000 shares authorized as of January 31, 2023 and 2022; 45,432,029 and 43,847,484 shares issued and outstanding as of January 31, 2023 and 2022, respectively	0	0
Additional paid-in capital	561,547	525,392
Accumulated other comprehensive income (loss)	(807)	(195)
Accumulated deficit	(410,476)	(341,982)
Total stockholders’ equity	150,264	183,215
Total liabilities and stockholders’ equity	$ 253,039	$ 276,742

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Jan. 31, 2023	Jan. 31, 2022
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Preferred stock, shares authorized (in shares)	200,000,000	200,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Common stock, shares authorized (in shares)	1,000,000,000	1,000,000,000
Common stock, shares issued (in shares)	45,432,029	43,847,484
Common stock, shares outstanding (in shares)	45,432,029	43,847,484

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Revenue:
Total revenue	$ 154,824	$ 123,542	$ 103,285
Cost of revenue:
Total cost of revenue	20,259	14,781	11,617
Gross profit	134,565	108,761	91,668
Operating expenses:
Research and development	57,760	51,639	39,000
Sales and marketing	111,067	89,372	70,248
General and administrative	33,390	24,008	15,500
Restructuring	1,663	0	0
Total operating expenses	203,880	165,019	124,748
Loss from operations	(69,315)	(56,258)	(33,080)
Interest expense	(101)	(656)	(6,970)
Other income (expense), net	1,960	(300)	1,111
Loss before income taxes	(67,456)	(57,214)	(38,939)
Provision for income taxes	1,038	1,015	1,044
Net loss	(68,494)	(58,229)	(39,983)
Cumulative dividends on Series G redeemable convertible preferred stock	0	(2,917)	(4,076)
Net loss attributable to common stockholders	(68,494)	(61,146)	(44,059)
Net loss attributable to common stockholders	$ (68,494)	$ (61,146)	$ (44,059)
Net loss per share attributable to common stockholders, basic (in shares)	$ (1.53)	$ (2.37)	$ (7.71)
Net loss per share attributable to common stockholders, diluted (in shares)	$ (1.53)	$ (2.37)	$ (7.71)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)	44,787,000	25,777,000	5,717,000
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)	44,787,000	25,777,000	5,717,000
Subscription
Revenue:
Total revenue	$ 142,895	$ 116,287	$ 96,936
Cost of revenue:
Total cost of revenue	10,762	8,529	6,074
Subscription \| License
Revenue:
Total revenue	19,885	19,008	14,032
Subscription \| Support and other
Revenue:
Total revenue	123,010	97,279	82,904
Services
Revenue:
Total revenue	11,929	7,255	6,349
Cost of revenue:
Total cost of revenue	$ 9,497	$ 6,252	$ 5,543

CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Statement of Comprehensive Income [Abstract]
Net loss	$ (68,494)	$ (58,229)	$ (39,983)
Other comprehensive income:
Net unrealized gains (losses) on investments, net of tax	(612)	(196)	1
Total comprehensive loss	$ (69,106)	$ (58,425)	$ (39,982)

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 6
-URI https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580

Reference 25: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

+ Details

CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($) $ in Thousands	Total	Redeemable Convertible Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance at Jan. 31, 2020		$ 155,506
Beginning balance (in shares) at Jan. 31, 2020		18,901,887
Increase (Decrease) in Temporary Equity
Issuance of Series G redeemable convertible preferred stock, net of issuance costs		$ 104,316
Issuance of Series G redeemable convertible preferred stock, net of issuance costs (in shares)		7,168,326
Ending balance at Jan. 31, 2021		$ 259,822
Ending balance (in shares) at Jan. 31, 2021		26,070,213
Beginning balance at Jan. 31, 2020	$ (213,216)		$ 0	$ 30,554	$ 0	$ (243,770)
Beginning balance (in shares) at Jan. 31, 2020			5,646,238
Increase (Decrease) in Stockholders' Equity
Issuance of common stock upon exercise of stock options	2,185			2,185
Issuance of common stock upon exercise of stock options (in shares)			553,067
Stock-based compensation	4,671			4,671
Net unrealized gains (losses) on investments	1				1
Net loss	(39,983)					(39,983)
Ending balance at Jan. 31, 2021	(246,342)		$ 0	37,410	1	(283,753)
Ending balance (in shares) at Jan. 31, 2021			6,199,305
Increase (Decrease) in Temporary Equity
Conversion of redeemable convertible preferred stock to common stock upon initial public offering		$ (259,822)
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)		(26,070,213)
Ending balance at Jan. 31, 2022		$ 0
Ending balance (in shares) at Jan. 31, 2022		0
Increase (Decrease) in Stockholders' Equity
Issuance of common stock upon exercise of stock options	7,495			7,495
Issuance of common stock upon exercise of stock options (in shares)			1,347,595
Conversion of redeemable convertible preferred stock to common stock upon initial public offering	259,822			259,822
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)			26,710,600
Issuance of common stock upon initial public offering, net of underwriting discounts and commissions and other issuance costs	209,924			209,924
Issuance of common stock upon initial public offering, net of underwriting discounts and commissions and other issuance costs (in shares)			9,589,999
Settlement of fractional shares paid in cash	(9)			(9)
Settlement of fractional shares paid in cash (in shares)			(15)
Stock-based compensation	10,750			10,750
Net unrealized gains (losses) on investments	(196)				(196)
Net loss	(58,229)					(58,229)
Ending balance at Jan. 31, 2022	$ 183,215		$ 0	525,392	(195)	(341,982)
Ending balance (in shares) at Jan. 31, 2022	43,847,484		43,847,484
Ending balance at Jan. 31, 2023		$ 0
Ending balance (in shares) at Jan. 31, 2023		0
Increase (Decrease) in Stockholders' Equity
Issuance of common stock upon exercise of stock options	$ 5,222			5,222
Issuance of common stock upon exercise of stock options (in shares)			817,753
Share purchases related to ESPP (in shares)			314,315
Stock Issued During Period, Value, Employee Stock Purchase Plan	4,484			4,484
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures			452,477
Stock-based compensation	26,449			26,449
Net unrealized gains (losses) on investments	(612)				(612)
Net loss	(68,494)					(68,494)
Ending balance at Jan. 31, 2023	$ 150,264		$ 0	$ 561,547	$ (807)	$ (410,476)
Ending balance (in shares) at Jan. 31, 2023	45,432,029		45,432,029

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Cash flows from operating activities
Net loss	$ (68,494)	$ (58,229)	$ (39,983)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization	3,171	2,824	2,006
Amortization of debt issuance costs	0	52	717
Debt prepayment costs	0	0	1,000
Stock-based compensation, net of amounts capitalized	25,786	10,750	4,671
Amortization of deferred commissions	16,996	13,763	10,402
Non-cash lease expense	2,909	0	0
Foreign currency transaction (gains) losses	524	382	(931)
Other	(416)	267	132
Changes in operating assets and liabilities
Accounts receivable	(3,537)	(730)	(5,524)
Deferred commissions	(17,590)	(20,495)	(13,450)
Prepaid expenses and other assets	(159)	(6,217)	56
Accounts payable	(495)	(491)	925
Accrued compensation and benefits	(3,497)	7,030	298
Accrued expenses and other liabilities	3,103	(493)	(279)
Operating lease liabilities	(2,754)	0	0
Deferred revenue	3,268	10,013	782
Net cash used in operating activities	(41,185)	(41,574)	(39,178)
Cash flows from investing activities
Purchases of short-term investments	(144,613)	(112,479)	(20,493)
Maturities and sales of short-term investments	126,893	21,268	900
Additions to property and equipment	(5,646)	(819)	(2,819)
Net cash used in investing activities	(23,366)	(92,030)	(22,412)
Cash flows from financing activities
Payments of debt	0	(25,000)	(57,402)
Proceeds from issuance of debt, net of issuance costs	0	0	31,402
Proceeds from issuance of Series G redeemable convertible preferred stock, net of issuance costs	0	0	104,316
Proceeds from exercise of stock options	5,222	7,495	2,185
Proceeds from issuance of common stock under ESPP	4,484	0	0
Proceeds from initial public offering, net of underwriting discounts and commissions	0	214,854	0
Payment for fractional shares in reverse stock split	0	(9)	0
Payments of deferred offering costs	0	(4,930)	0
Net cash provided by financing activities	9,706	192,410	80,501
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(397)	(415)	162
Net increase (decrease) in cash, cash equivalents and restricted cash	(55,242)	58,391	19,073
Cash, cash equivalents and restricted cash
Beginning of period	96,231	37,840	18,767
End of period	40,989	96,231	37,840
Cash and cash equivalents	40,446	95,688	37,297
Restricted cash included in other assets	543	543	543
Total cash, cash equivalents and restricted cash	40,989	96,231	37,840
Supplemental disclosures of cash activities
Cash paid for income taxes	781	797	866
Cash paid for interest	101	616	5,951
Non-cash investing and financing activities:
Stock-based compensation capitalized as internal-use software costs	663	0	0
Net change in unrealized gains or losses on available-for-sale debt securities	(612)	(196)	0
Change in purchases of property and equipment included in accounts payable and other accrued liabilities	15	(212)	309
Change in deferred offering costs included in accounts payable and other accrued liabilities	0	(1,084)	1,084
Conversion of redeemable convertible preferred stock to common stock	$ 0	$ 259,822	$ 0

Organization, Consolidation and Presentation of Financial Statements	12 Months Ended
	Jan. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Business	Description of BusinessCouchbase, Inc. provides an enterprise-class, multi-cloud NoSQL database architected on top of an open source foundation. Couchbase was incorporated in the State of Delaware in 2008 and is headquartered in Santa Clara, California. In these notes to the consolidated financial statements, the “Company,” “Couchbase” “we,” “us,” and “our” refers to Couchbase, Inc. and its subsidiaries on a consolidated basis.

Basis of Presentation and Summary of Significant Accounting Policies

12 Months Ended

Jan. 31, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation and Summary of Significant Accounting Policies

Basis of Presentation

The accompanying consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America (“GAAP”). The Company’s consolidated financial statements and accompanying notes include the accounts of the Company and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.

Initial Public Offering

In July 2021, the Company completed its initial public offering (“IPO”), for the sale and issuance of 9,589,999 shares of its common stock at $24.00 per share, which included 1,250,869 shares issued pursuant to the exercise of the underwriters’ option to purchase additional shares. The Company received net proceeds of $214.9 million, after deducting underwriters’ discounts and commissions and before consideration of other issuance costs. In connection with the IPO, all 26,710,600 shares of outstanding redeemable convertible preferred stock automatically converted into an equivalent number of shares of common stock, inclusive of 640,387 shares of additional stock issued related to preferred stock conversion and dividend features.

Reverse Stock Split

On June 30, 2021, the Company effected a 2.5-for-1 reverse stock split of its outstanding common stock, common stock warrants, preferred stock and stock option awards. All issued and outstanding shares of common stock, common stock warrants, preferred stock, stock option awards and per share data have been adjusted in these consolidated financial statements, on a retrospective basis, to reflect the reverse stock split for all periods presented. The par value of the common stock and preferred stock was not adjusted because of the reverse stock split.

Fiscal Year

The Company’s fiscal year ends on January 31. References to fiscal 2023, 2022 and 2021 refer to the years ended January 31, 2023, 2022 and 2021, respectively.

Segment Information

The Company has a single operating and reportable segment. The Company’s chief operating decision maker is its Chief Executive Officer, who reviews financial information presented on a consolidated basis for purposes of making operating decisions, assessing financial performance and allocating resources.

Use of Estimates

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts stated in the financial statements and accompanying notes. Such estimates include standalone selling prices for each distinct performance obligation, capitalized internal-use software costs, expected period of benefit for deferred commissions, valuation of the Company’s common stock prior to the IPO in July 2021, valuation of stock-based awards, the determination of allowance for doubtful accounts, the incremental borrowing rate used to measure operating lease liabilities, and accounting for income taxes. The Company bases its estimates on historical experience and assumptions that management considers reasonable.

The Company assesses these estimates on a regular basis; however, actual results could differ from these estimates. Estimates and assumptions about future events and their effects, including the impact of macroeconomic conditions such as inflation and foreign exchange fluctuations, cannot be determined with certainty and therefore require increased judgment. These estimates and assumptions may change in future periods and will be recognized in the consolidated financial statements as new events occur and additional information becomes known. To the extent the Company’s actual results differ materially from those estimates and assumptions, the Company’s future financial statements could be affected.

Foreign Currency

The reporting currency of the Company is the United States dollar (“U.S. dollar”). The functional currency of each of the Company’s foreign subsidiaries is the U.S. dollar. Accordingly, each foreign subsidiary remeasures monetary assets and liabilities at period-end exchange rates, while nonmonetary items are remeasured at historical rates. Revenue and expense items are remeasured at the exchange rates in effect on the day the transaction occurred, except for those expenses related to non-monetary assets and liabilities, which are remeasured at historical exchange rates. Remeasurement adjustments are recognized in other income (expense), net in the consolidated statements of operations. The Company had foreign currency transaction gains (losses) of $(0.5) million, $(0.4) million and $0.9 million for the years ended January 31, 2023, 2022 and 2021, respectively.

Revenue Recognition

The Company accounts for revenue in accordance with Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers (“ASC 606”).

Revenue is derived from sales of subscriptions and services.

Subscription revenue primarily consists of revenue from: (1) term-based software licenses sold in conjunction with post-contract support (“PCS” or “Support”) and (2) a consumption-based database-as-a-service offering. PCS bundled with software licenses includes internet, email and phone support, bug fixes and the right to receive unspecified software updates and upgrades released when and if available during the subscription term. The software license is presented as “License.” PCS and database-as-a-service revenue are presented as “Support and other” in the Company’s consolidated statements of operations. The software license in the subscription is a distinct performance obligation from PCS. License revenue is recognized upon transfer when the customer has received access to the software. The PCS is recognized ratably over the term of the arrangement beginning on the date when access to the subscription is made available to the customer and represents a substantial majority of the Company’s revenue. Performance obligations related to the database-as-a-service offering are recognized on a usage-basis as the consumption of this service represents a direct measurement of the value to the customer of the services transferred to date relative to the remaining services promised under the contract. The non-cancelable term of the Company’s subscription arrangements typically ranges from one to three years but may be longer or shorter in limited circumstances. The Company typically bills subscription revenue annually in advance. Customer on-demand arrangements generally have a monthly stated contract term and are billed monthly. “Other” revenue was not material for the years ended January 31, 2023, 2022 and 2021.

The Company’s services revenue is derived from professional services for the implementation or configuration of its platform and training. Professional services are provided primarily on a fixed fee basis and are generally invoiced upfront, and training is generally priced on number of seats purchased. These services are distinct from software licenses and PCS. Revenue for fixed fee arrangements is recognized on a proportional performance basis as the services are performed. Revenue for training is recognized upon delivery.

The Company determines revenue recognition in accordance with ASC 606 through the following five steps:

•Identify the contract with a customer: The Company usually contracts with its customers using an order form that is governed by the Company’s standard electronic software licensing or master service agreement, or by the master sales agreement executed between the Company and the customer. A fully executed order form creates enforceable rights and obligations. The Company uses multiple factors such as historical payments experience, credit status and financial status in determining the customer’s ability to pay. At contract inception, the Company evaluates whether two or more contracts should be combined and accounted for as a single contract and whether the combined or single contract includes more than one performance obligation. The Company uses factors such as timing of the contract, negotiation teams involved and additional subscriptions or services contracted to determine combination.

•Identify performance obligations in the contract: The Company enters into contracts that can include various combinations of products and services that are both (1) capable of being distinct, whereby the

customer can benefit from the product or service either on its own or together with other resources that are readily available from third parties or from the Company and (2) distinct in the context of the contract, whereby the transfer of the products or services is separately identifiable from other promises in the contract.

•Determine transaction price: The transaction price is the consideration the Company expects to receive in exchange for those products or services. Variable consideration is included in the transaction price if, in the Company’s judgment, it is probable that a significant future reversal of cumulative revenue recognized under the contract will not occur. Revenue is recognized net of any taxes collected from customers, which are subsequently remitted to governmental entities (e.g., sales and other indirect taxes).

•Allocate transaction price to the performance obligations in the contract: Arrangements that include multiple performance obligations require an allocation of the transaction price to each performance obligation based on the relative SSP of the performance obligation. The Company also considers if there are any additional material rights inherent in a contract, and if so, the Company allocates a portion of the transaction price to such rights based on SSP of the material right. When appropriate, the Company determines SSP based on the price at which the performance obligation has previously been sold through past transactions. The Company determines SSP for performance obligations with no observable evidence using adjusted market, cost plus or residual methods. When the SSP of a subscription including bundled software license and PCS is highly variable and the contract also includes additional performance obligations with observable SSP, the Company first allocates the transaction price to the performance obligations with established SSPs and then applies the residual approach to allocate the remaining transaction price to the subscription. If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation.

•Recognize revenue when or as the Company satisfies a performance obligation: The Company recognizes revenue upon transfer of control of promised products or services. Revenue is recognized based on type of performance obligation.

Allocation of Overhead Costs

Overhead costs that are not substantially dedicated for use by a specific functional organization are allocated based on headcount. Such costs include costs associated with office facilities, depreciation and amortization of property and equipment and IT personnel-related costs and other expenses, such as software and subscription services.

Cost of Revenue

Cost of subscription revenue consists primarily of personnel-related costs associated with the Company’s customer support organization, including salaries, benefits, bonuses and stock-based compensation, expenses associated with software and subscription services dedicated for use by the Company’s customer support organization, third-party cloud infrastructure expenses, amortization of costs associated with capitalized internal-use software and allocated overhead. There is no cost of revenue associated with the Company’s license revenue.

Cost of services revenue consists primarily of personnel-related costs associated with the Company’s professional services and training organization, including salaries, benefits, bonuses and stock-based compensation, costs of contracted third-party partners for professional services, expenses associated with software and subscription services dedicated for use by the Company’s service organization, travel-related expenses and allocated overhead.

Advertising

Advertising costs are charged to sales and marketing expenses in the consolidated statement of operations in the period incurred. These costs were not material for the years ended January 31, 2023, 2022 and 2021.

Stock-Based Compensation

The Company measures and recognizes compensation expense for all stock-based awards, including restricted stock units, stock options, and the ESPP, to employees, consultants and nonemployee directors based on the estimated fair value of the awards on the grant date. The fair value of stock options and purchase rights under the ESPP are estimated using the Black-Scholes option-pricing model. The fair value of market-based performance restricted stock unit awards is estimated, at the date of grant, using the Monte Carlo Simulation Model. The Black-Scholes and Monte Carlo Simulation valuation models are affected by the fair value of the Company’s common stock as well as assumptions regarding a number of other complex and subjective variables. These variables include expected stock price volatility over the expected term of the award, the risk-free interest rate for the expected term of the award and expected dividends.

Stock-based compensation expense for restricted stock units and stock options is recognized over the requisite service period. Forfeitures are accounted for as they occur. For awards with only a service condition, the Company recognizes stock-based compensation using the straight-line method over the requisite service period for the entire award. For awards with a market condition, we recognize expense separately for each vesting tranche regardless of whether the market condition is satisfied. Stock-based compensation expense for the ESPP is recognized on a straight-line basis over the offering period.

Income Taxes

The Company is subject to income taxes in the United States and certain foreign jurisdictions.

The Company records a provision for income taxes for the anticipated tax consequences of the reported results of operations using the asset and liability method. Under this method, the Company recognizes deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts for financial reporting purposes and the tax bases of assets and liabilities, as well as for loss and tax credit carryforwards. The deferred assets and liabilities are measured using the statutorily enacted tax rates anticipated to be in effect when those tax assets and liabilities are expected to be realized or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period that includes the enactment date.

A valuation allowance is established if, based upon the available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. The Company considers all available evidence, both positive and negative, including historical levels of income, expectations and risks associated with estimates of future taxable income in assessing the need for a valuation allowance.

The Company’s tax positions are subject to income tax audits by multiple tax jurisdictions throughout the world. The Company recognizes the tax benefit of an uncertain tax position only if it is more likely than not the position will be sustainable upon examination by the taxing authority, including resolution of any related appeals or litigation processes. This evaluation is based on all available evidence and assumes that the tax authorities have full knowledge of all relevant information concerning the tax position. The tax benefit recognized is measured as the largest amount of benefit that is more likely than not to be realized upon ultimate settlement with the taxing authority. The Company recognizes interest accrued and penalties related to unrecognized tax benefits in the provision for income taxes. The Company makes adjustments to these reserves in accordance with the income tax guidance when facts and circumstances change, such as the closing of a tax audit or the refinement of an estimate.

Net Loss Per Share Attributable to Common Stockholders

Basic and diluted net loss per share attributable to common stockholders is computed in conformity with the two-class method required for participating securities. The Company considered all series of its redeemable convertible preferred stock to be participating securities as the holders of such stock had the right to receive nonforfeitable dividends on a pari passu basis in the event that a dividend was paid on common stock. Under the two-class method, the net loss attributable to common stockholders was not allocated to the redeemable convertible preferred stock as the preferred stockholders did not have a contractual obligation to share in the Company’s losses.

Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share is computed by giving effect to all potentially dilutive shares to the extent they are dilutive. For purposes of this calculation, stock options, redeemable convertible preferred stock, common stock warrants, RSUs and employee stock purchase rights under the ESPP are considered to be potentially dilutive shares but have been excluded from the calculation of diluted net loss per share attributable to common stockholders as their effect is anti-dilutive.

Cash and Cash Equivalents

The Company considers all highly liquid investments with original or remaining maturities of three months or less when purchased to be cash and cash equivalents.

Restricted Cash

Restricted cash is held in a money market account in connection with a lease agreement for the Company’s facilities. Restricted cash is included in other noncurrent assets on the consolidated balance sheets as the related lease expires more than one year from the balance sheet date.

Short-Term Investments

The Company determines the appropriate classification of its investments at the time of purchase. As the Company views these securities as available to support current operations, it accounts for these debt securities as available-for-sale and classifies them as current assets on its consolidated balance sheets. These securities are recorded at estimated fair value. Unrealized gains and losses for available-for-sale securities are included in accumulated other comprehensive income (loss). The Company periodically evaluates its investments to assess whether those with unrealized loss positions are other-than-temporarily impaired. The Company considers impairments to be other than temporary if they are related to deterioration in credit risk or if it is more likely than not that the Company will sell the securities before the recovery of their cost basis. If the Company does not intend to sell a security and it is not more likely than not that it will be required to sell the security before recovery, the unrealized loss is separated into an amount representing the credit loss, which is recognized in other income (expense), net, and the amount related to all other factors, which is recorded in accumulated other comprehensive income (loss).

Realized gains and losses and declines in value judged to be other than temporary are determined based on the specific identification method and are reported in other income (expense), net in the consolidated statements of operations. Realized gains and losses for the years ended January 31, 2023, 2022 and 2021 were not material.

Accounts Receivable

Accounts receivable includes billed and unbilled receivables, net of allowance for doubtful accounts. Accounts receivable are recorded at the invoiced amount and are non-interest bearing. The Company records a provision for doubtful accounts based on historical experience and a detailed assessment of the collectability of its accounts receivable. In estimating the allowance for doubtful accounts, the Company considers, among other factors, the aging of the accounts receivable, its historical write-offs, the credit worthiness of customers and general economic conditions. Account balances are charged off against the allowance when the Company believes it is probable the receivable will not be recovered. Actual write-offs may either be in excess of or less than the estimated allowance.

Unbilled accounts receivable represents revenue recognized on contracts in excess of invoiced amounts. Unbilled accounts receivable as of January 31, 2023 and 2022 were not material.

The following table presents the changes in the allowance for doubtful accounts (in thousands):


	Year Ended January 31,
	2023		2022		2021
Beginning balance	$	108	$	73	$	81
Add: bad debt expense	69		41		84
Less: write-offs, net of recoveries	(4)		(6)		(92)
Ending balance	$	173	$	108	$	73

Concentration of Credit Risk

Financial instruments that potentially subject the Company to credit risk primarily consist of cash, cash equivalents, restricted cash, short-term investments and accounts receivable. The Company maintains its cash and cash equivalents, restricted cash and short-term investments with high-quality financial institutions. Cash equivalents consist of money market funds which are invested through financial institutions in the United States. Deposits, including those held in foreign branches of global banks, may exceed the amount of insurance provided on such deposits. The Company has not experienced any losses on these deposits.

For its accounts receivable, the Company is exposed to credit risk in the event of nonpayment by customers to the extent of the amounts recorded on the consolidated balance sheet. Generally, credit risk with respect to accounts receivable is diversified due to the number of entities comprising the Company’s customer base and their dispersion across different geographies and industries. The Company performs ongoing credit evaluations on certain customers and generally does not require collateral on accounts receivable. The Company maintains an allowance for doubtful accounts and historically bad debts have not been material.

No customer accounted for 10% or more of total revenue for the years ended January 31, 2023, 2022 and 2021. One customer accounted for approximately 12% of gross accounts receivable as of January 31, 2023. No customer accounted for 10% or more of gross accounts receivable as of January 31, 2022.

Fair Value of Financial Instruments

The Company accounts for certain of its financial assets and liabilities at fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The accounting guidance establishes a three-tiered hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value as follows:

Level 1: Observable inputs, such as quoted prices in active markets for identical assets or liabilities.

Level 2: Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

Property and Equipment, Net

Property and equipment are recorded at cost, less accumulated depreciation and amortization. Depreciation and amortization is computed using the straight-line method over the estimated useful lives of the assets, which is as follows:


Computer equipment			3 years
Furniture and fixtures			5 years
Leasehold improvements			Shorter of lease term or estimated useful life
Capitalized internal-use software			3 years

When assets are retired or otherwise disposed of, the cost and accumulated depreciation and amortization are removed from the consolidated balance sheets, and any resulting gain or loss is reflected in the consolidated statements of operations in the period realized. Maintenance and repairs are charged to expense in the consolidated statements of operations in the period incurred.

Capitalized Internal-Use Software

The Company capitalizes qualifying internal-use software development costs, including personnel-related costs that are incurred during the application development stage. Capitalization of costs begins when two criteria are met: (1) the preliminary project stage is completed and (2) it is probable that the software will be completed and used for its intended function. Capitalization ceases when the software is substantially complete and ready for its intended use, including the completion of all significant testing. Costs related to preliminary project activities and post-implementation operating activities are expensed as incurred.

Capitalized internal-use software costs are included in property and equipment, net on the consolidated balance sheets. These costs are amortized on a straight-line basis over their estimated useful life commencing when assets are initially placed into service for their intended use. Amortization expense of capitalized internal-use software costs was included in cost of subscription revenue in the consolidated statements of operations.

Leases

Effective February 1, 2022, the consolidated financial statements reflect the adoption of ASC 842, Leases, using the modified retrospective method. Refer to Accounting Pronouncements Recently Adopted below regarding the adoption impact of ASC 842.

Lease right-of-use (“ROU”) assets and liabilities, with the exception of short-term leases, are recognized at the commencement date based on the present value of lease payments over the lease term. The Company estimates the discount rate based on the information available at the lease commencement date unless the implicit rate is readily determinable. For leases that commenced prior to the adoption of ASC 842, the Company used the discount rate on February 1, 2022. The lease ROU assets also include any lease payments made and exclude lease incentives such as tenant improvement allowances. Options to extend the lease term are included in the lease term when it is reasonably certain the extension option will be exercised.

Impairment of Long-Lived Assets

Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. Impairment exists for property and equipment if the carrying amounts of such assets exceed the estimates of future net undiscounted cash flows expected to be generated by such assets. An impairment charge is recognized for the amount by which the carrying amount of the asset, or asset group, exceeds its fair value. No impairment of long-lived assets occurred during the years ended January 31, 2023, 2022 and 2021.

Deferred Commissions

The Company capitalizes certain sales commissions, including related payroll taxes, earned by the Company’s sales force, which are considered to be incremental costs that would not be incurred absent entering into the contract with the customer. Commissions earned on the initial acquisition of a contract are amortized based on the expected future revenue stream over a period of benefit of three years. The Company determined the period of benefit by taking into consideration its customer contracts, its technological life and other factors. Commissions paid for renewal contracts are not commensurate with the commissions paid for initial acquisition of a contract and are amortized over the related contractual renewal period. The deferred commission amounts are recoverable through the future revenue streams under the customer contracts. Amortization of deferred commissions is included in sales and marketing expenses in the consolidated statements of operations. Impairment losses related to deferred sales commissions were immaterial for the years ended January 31, 2023, 2022 and 2021. Commissions that will be amortized within the next twelve months are classified as current with the remainder classified as non-current on the consolidated balance sheets.

Deferred Revenue

The Company records deferred revenue when the Company receives customer payments in advance of satisfying the performance obligations on the Company’s contracts. Deferred revenue also includes amounts that have been invoiced but not yet collected, classified as accounts receivable, when the Company has an enforceable right to invoice. The portion of deferred revenue that is anticipated to be recognized as revenue during the succeeding twelve-month period is recorded as deferred revenue, current with the remainder classified as deferred revenue, noncurrent on the consolidated balance sheets.

Recent Accounting Pronouncements

Accounting Pronouncements Recently Adopted

In August 2018, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2018-15, Intangibles—Goodwill and Other— Internal-Use Software, which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal use software license). The accounting for the service element of a hosting arrangement that is a service contract is not affected by the amendments in this ASU. The Company adopted this guidance on February 1, 2022 prospectively for implementation costs incurred after the date of adoption, and the adoption did not have a material impact on the consolidated financial statements.

In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which simplifies the accounting for income taxes by amending and clarifying existing guidance in ASC 740, as well as removing certain exceptions within ASC 740. The Company adopted this guidance on February 1, 2022, and the adoption did not have a material impact on the consolidated financial statements.

Leases: In February 2016, the FASB issued Accounting Standards Update (“ASU”) No. 2016-02 and several amendments, codified as ASC 842, Leases, which amends the existing accounting standards for leases. The new standard requires lessees to record a ROU asset and a corresponding lease liability on the balance sheet (with the exception of short-term leases). For lessees, leases will continue to be classified as either operating or financing in the income statement. The Company adopted the guidance on February 1, 2022 utilizing the modified retrospective transition method through a cumulative-effect adjustment at the beginning of the first quarter of fiscal 2023.

The Company elected the package of transitional practical expedients upon which, among other provisions, allowed the Company not to reassess under the new standard prior conclusions about lease identification, lease classification and initial direct costs, for any existing leases on the adoption date. The Company elected not to record leases that, at the commencement date, have a lease term of twelve months or less. The Company did not elect to apply the hindsight practical expedient when determining lease term and assessing impairment of ROU assets. The Company also did not elect to combine its lease and non-lease components. Non-lease components that are not fixed are expensed as incurred as variable lease payments.

Upon adoption of ASC 842, the Company recognized operating lease ROU assets and operating lease liabilities of $6.7 million and $7.5 million, respectively, as of February 1, 2022 and did not include any retrospective adjustments to comparative periods to reflect the adoption of ASC 842. The difference of $0.8 million between operating lease ROU assets and operating lease liabilities at the adoption date related to deferred rent.

Accounting Pronouncements Not Yet Adopted

Under the JOBS Act, the Company meets the definition of an emerging growth company and can delay adopting new or revised accounting standards issued after the enactment of the JOBS Act until such time as those standards apply to private companies. The Company has elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the Company is no longer an emerging growth company or until the Company affirmatively and irrevocably opts out of the extended transition period.

In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which requires a financial asset measured at amortized cost basis to be presented at the net amount expected to be collected, with further clarifications made more recently. For trade receivables, loans and other financial instruments, the Company will be required to use a forward-looking expected loss model rather than the incurred loss model for recognizing credit losses which reflects losses that are probable. Credit losses relating to available-for-sale debt securities are required to be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. The Company adopted this standard on February 1, 2023 and is evaluating the impact the adoption will have on the consolidated financial statements, however such impact is not expected to be material.

Cash Equivalents and Short-Term Investments

12 Months Ended

Jan. 31, 2023

Cash and Cash Equivalents [Abstract]

Cash Equivalents and Short-Term Investments

The following tables summarize the Company’s cash equivalents and short-term investments (in thousands):


	As of January 31, 2023
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value
Cash Equivalents
Money market funds	$	29,239	$	—	$	—	$	29,239
Corporate debt securities	1,122		—		—		1,122
Total cash equivalents	30,361		—		—		30,361
Short-Term Investments
U.S. government treasury securities	71,981		1		(729)		71,253
Commercial paper	31,500		—		—		31,500
Corporate debt securities	11,952		—		(50)		11,902
U.S. government agency securities	7,839		3		(1)		7,841
Asset-backed securities	5,391		—		(31)		5,360
Total short-term investments	128,663		4		(811)		127,856
Total	$	159,024	$	4	$	(811)	$	158,217


	As of January 31, 2022
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value
Cash Equivalents
Money market funds	$	86,505	$	—	$	—	$	86,505
Total cash equivalents	86,505		—		—		86,505
Short-Term Investments
U.S. government treasury securities	39,340		—		(129)		39,211
Commercial paper	40,966		—		(1)		40,965
Corporate debt securities	30,156		—		(66)		30,090
Total short-term investments	110,462		—		(196)		110,266
Total	$	196,967	$	—	$	(196)	$	196,771

During the years ended January 31, 2023, 2022 and 2021, the Company did not reclassify any amounts to earnings from accumulated other comprehensive income (loss) related to unrealized gains or losses in other income (expense), net in the consolidated statements of operations.

As of January 31, 2023, the Company’s short-term investments consisted of $122.0 million and $5.9 million with a contractual maturity date of less than one year and greater than one year, respectively. As of January 31, 2022, the Company’s short-term investments consisted of $108.3 million and $2.0 million with a contractual maturity date of less than one year and greater than one year, respectively.

The Company’s gross unrealized losses and fair values for short-term investments that were in an unrealized loss position as of January 31, 2023 and 2022, aggregated by investment category and the length of time that individual securities have been in a continuous loss position were as follows (in thousands):


	As of January 31, 2023
	Less Than 12 Months				12 Months or Greater				Total
	Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value
U.S. government treasury securities	$	(729)	$	64,397	$	—	$	—	$	(729)	$	64,397
Corporate debt securities	(49)		8,909		(1)		1,999		(50)		10,908
U.S. government agency securities	(1)		1,918		—		—		(1)		1,918
Asset-backed securities	(31)		5,359		—		—		(31)		5,359
Total	$	(810)	$	80,583	$	(1)	$	1,999	$	(811)	$	82,582


	As of January 31, 2022
	Less Than 12 Months				12 Months or Greater				Total
	Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value
U.S. government treasury securities	$	(129)	$	39,211	$	—	$	—	$	(129)	$	39,211
Commercial paper	(1)		2,497		—		—		(1)		2,497
Corporate debt securities	(66)		30,090		—		—		(66)		30,090
Total	$	(196)	$	71,798	$	—	$	—	$	(196)	$	71,798

As of January 31, 2023 and 2022, the Company had 27 and 25 short-term investments in an unrealized loss position, respectively. During the years ended January 31, 2023, 2022 and 2021, the Company had no other-than-temporary impairments of short-term investments.

Fair Value Measurements

12 Months Ended

Jan. 31, 2023

Fair Value Disclosures [Abstract]

Fair Value Measurements

Level 1: Observable inputs, such as quoted prices in active markets for identical assets or liabilities.

Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The carrying amounts reflected on the consolidated balance sheets for cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate fair value due to the short maturities of those instruments.

The following tables present the fair value hierarchy for the Company’s assets measured at fair value on a recurring basis (in thousands):


	As of January 31, 2023
	Level 1		Level 2		Total
Cash Equivalents
Money market funds	$	29,239	$	—	$	29,239
Corporate debt securities	—		1,122		1,122
Total cash equivalents	29,239		1,122		30,361
Short-Term Investments
U.S. government treasury securities	—		71,253		71,253
Commercial paper	—		31,500		31,500
Corporate debt securities	—		11,902		11,902
U.S. government agency securities	—		7,841		7,841
Asset-backed securities	—		5,360		5,360
Total short-term investments	—		127,856		127,856
Total	$	29,239	$	128,978	$	158,217


	As of January 31, 2022
	Level 1		Level 2		Total
Cash Equivalents
Money market funds	$	86,505	$	—	$	86,505
Total cash equivalents	86,505		—		86,505
Short-Term Investments
U.S. government treasury securities	—		39,211		39,211
Commercial paper	—		40,965		40,965
Corporate debt securities	—		30,090		30,090
Total short-term investments	—		110,266		110,266
Total	$	86,505	$	110,266	$	196,771

The Company classifies its money market funds within Level 1 of the fair value hierarchy because they are valued based on quoted market prices in active markets. The Company classifies its U.S. government agency securities, asset-backed securities, commercial paper, corporate debt securities, and U.S. government treasury securities within Level 2 because they are valued using inputs other than quoted prices which are directly or indirectly observable in the market, including readily available pricing sources for the identical underlying security which may not be actively traded.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Balance Sheet Components

12 Months Ended

Jan. 31, 2023

Balance Sheet Related Disclosures [Abstract]

Balance Sheet Components

Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in thousands):


	As of January 31,
	2023		2022
Prepaid expenses	$	4,140	$	4,518
Prepaid software	2,560		2,297
Other current assets	1,534		1,744
Total prepaid expenses and other current assets	$	8,234	$	8,559

Property and Equipment, Net

Property and equipment, net consisted of the following (in thousands):


	As of January 31,
	2023		2022
Computer equipment	$	3,586	$	3,711
Furniture and fixtures	342		412
Capitalized internal-use software	7,884		5,772
Leasehold improvements	1,889		1,582

Construction in progress—capitalized internal-use software	3,395		—
Total gross property and equipment	17,096		11,477
Accumulated depreciation and amortization	(9,666)		(7,189)
Total property and equipment, net	$	7,430	$	4,288

Depreciation and amortization expense was $3.2 million, $2.8 million and $2.0 million for the years ended January 31, 2023, 2022 and 2021, respectively. Included in these amounts were the amortization of capitalized internal-use software development costs of $2.2 million, $1.9 million and $1.1 million for the years ended January 31, 2023, 2022 and 2021, respectively.

Accrued Compensation and Benefits

Accrued compensation and benefits consisted of the following (in thousands):


	As of January 31,
	2023		2022
Accrued bonus	$	5,944	$	5,557
Accrued commissions	3,593		4,226
Accrued payroll and benefits	1,995		2,863
Employee contributions under the ESPP	1,109		3,497
Total accrued compensation and benefits	$	12,641	$	16,143

Other Accrued Liabilities

Other accrued liabilities consisted of the following (in thousands):


	As of January 31,
	2023		2022
Accrued professional fees	$	1,020	$	717
Sales and value added tax payable	737		671
Income taxes payable	743		414
Accrued restructuring	1,567		—
Other	2,009		1,429
Total other accrued liabilities	$	6,076	$	3,231

Deferred Revenue and Remaining Performance Obligations

12 Months Ended

Jan. 31, 2023

Revenue from Contract with Customer [Abstract]

Deferred Revenue and Remaining Performance Obligations

The following table presents the deferred revenue balances (in thousands):


	As of January 31,
	2023		2022

Deferred revenue, current	$	71,716	$	69,010
Deferred revenue, noncurrent	3,275		2,713
Total deferred revenue	$	74,991	$	71,723

Changes in the deferred revenue balances during the years ended January 31, 2023 and 2022 were as follows (in thousands):


	Year Ended January 31,
	2023		2022

Beginning balance	$	71,723	$	61,710
Performance obligations satisfied during the period that were included in the deferred revenue balance at the beginning of the year	(66,480)		(57,809)
Increases due to invoicing prior to satisfaction of performance obligations	69,748		67,822
Ending balance	$	74,991	$	71,723

Remaining performance obligations (“RPOs”) represent the amount of contracted future revenue that has not yet been recognized, including both deferred revenue and non-cancelable contracted amounts that will be invoiced and recognized as revenue in future periods.

As of January 31, 2023, the Company’s RPOs were $165.9 million. The Company expects to recognize revenue of $117.2 million of these remaining performance obligations over the next twelve months with the remaining balances recognized thereafter.

- Definition

The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-URI https://asc.fasb.org/topic&trid=49130388

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 10
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)(2)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 9
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 15
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

+ Details

Debt	12 Months Ended
Debt	Jan. 31, 2023
Debt Disclosure [Abstract]
Debt	7. Debt Interest expense was $0.1 million, $0.7 million and $7.0 million for the years ended January 31, 2023, 2022 and 2021, respectively. The effective interest rate was 4.1% and 16.0% for the years ended January 31, 2022 and 2021, respectively. Term Loan In August 2018, the Company entered into an agreement for a term loan with a certain lender, which was amended in April 2019 and in June 2020 (the “Amended Loan”). The Amended Loan provided maximum borrowings of up to $25.0 million, maturing in June 2024. In January 2021, the Company repaid all outstanding indebtedness owed pursuant to the Amended Loan and terminated the agreement. Pursuant to the termination of the Amended Loan, the related security interests have been removed and the covenants shall be of no further force and effect. In connection with the April 2019 amendment, the Company issued warrants to purchase 105,350 shares of the Company’s common stock at $7.48 per share, exercisable over 10 years. The fair value of the warrants was recorded to equity and as a debt discount that was amortized to interest over the term of the loan. The total fair value of the common stock warrants was $0.4 million. As of January 31, 2023, all warrants were outstanding and exercisable. Credit Facility In November 2017, the Company entered into a line of credit agreement with Silicon Valley Bank, or Credit Facility, providing the Company the ability to borrow up to $10.0 million from a revolving line of credit with an original maturity date in November 2018. Borrowings under the line of credit bear interest at a floating per annum rate equal to one half of one percentage point (0.50%) above the prime rate, which interest shall be payable monthly. The line of credit is secured with a pledge on substantially all the assets of the Company, except any intellectual property and is subject to a minimum revenue covenant. In November 2018, the Company entered into an amendment with Silicon Valley Bank to increase the line of credit limit to $15.0 million and extend the maturity date to November 2019. In April 2019, an amendment was entered into with the Silicon Valley Bank to decrease the line of credit to $10.0 million. In October 2019, an amendment was entered into with Silicon Valley Bank to extend the maturity of the line of credit to November 2020. In November 2020, the Company entered into an amendment with Silicon Valley Bank to extend the maturity of the line of credit to February 2021. In January 2021, the Company entered into an amendment with Silicon Valley Bank to increase the line of credit limit to $40.0 million and extend the maturity date to January 2024. Upon the execution of this amendment, the Company borrowed $25.0 million from the line of credit. The outstanding principal balance is due at maturity with interest payable monthly. The line of credit bears a variable annual interest rate of the prime rate plus 0.5%. The Company is required to pay a fee equal to 0.25% per annum on the unused portion of the line of credit. The Company is also subject to a termination fee ranging from 0.5% to 1.0% of the line of credit if the Company terminates the agreement prior to the maturity date. The amendment also added certain financial covenants, including covenants related to certain financial metrics, that if not met, would limit the amount of additional borrowings under the line of credit. The amended line of credit agreement requires the company to maintain an adjusted quick ratio (as defined by the agreement) of at least 1.15 to 1.0. The line of credit agreement also contains certain customary affirmative and negative covenants as well as customary events of default, subject to certain exceptions, including restrictions on the Company’s ability to, among other things, incur debt and liens, maintain collateral accounts, undergo fundamental changes including mergers or consolidations, dispose assets including selling, transferring or assigning assets, pay dividends or other distributions or make or permit payments on any subordinated debt. The Company was in compliance with the financial covenants under the line of credit as of January 31, 2023. The Company repaid the outstanding principal of its revolving line of credit of $25.0 million during the year ended January 31, 2022. As of January 31, 2023, $40.0 million was available for borrowing under the line of credit. On March 14, 2023, Silicon Valley Bridge Bank, N.A. announced that it had assumed the obligations and commitments of former Silicon Valley Bank, including the line of credit.

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-URI https://asc.fasb.org/topic&trid=2208564

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (h)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(c))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (g)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1E
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (i)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

+ Details

Leases

12 Months Ended

Jan. 31, 2023

Leases [Abstract]

Lessee, Operating Leases

Leases

The Company leases facilities under non-cancelable operating leases, primarily for rent of office space. The leases have various expiration dates through November 2027, some of which include options to extend the leases for up to three years. The Company does not have any finance leases.

Operating lease costs were $2.9 million for the year ended January 31, 2023. Variable lease costs were $0.8 million for the year ended January 31, 2023. Short-term lease costs were $0.3 million for the year ended January 31, 2023.

The following table presents supplemental cash flow information related to leases (in thousands):


	Year Ended January 31, 2023
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash outflows from operating leases	$	3,169
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$	2,811

The following table presents supplemental balance sheet information related to operating leases (in thousands, except for lease term and discount rate):


	As of January 31, 2023
Operating lease right-of-use assets	$	6,940
Operating lease liabilities	$	3,117
Operating lease liabilities, noncurrent	4,543
Total operating lease liabilities	$	7,660
Weighted-average remaining lease term	2.7 years
Weighted-average discount rate	3.8		%

As of January 31, 2023, remaining maturities of operating lease liabilities were as follows (in thousands):


Period	Operating Leases
Fiscal 2024	$	3,309
Fiscal 2025	2,975
Fiscal 2026	1,172
Fiscal 2027	352
Fiscal 2028 and thereafter	251
Total lease payments	8,059
Less: imputed interest	(399)
Total	$	7,660

Future minimum lease payments under non-cancelable operating leases as of January 31, 2022 under ASC 840 were as follows (in thousands):


Year Ending January 31,	Operating Leases
2023	$	2,845
2024	2,638
2025	2,178
2026	362
2027 and thereafter	—
Total	$	8,023

Commitments and Contingencies

12 Months Ended

Jan. 31, 2023

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Other Contractual Commitments

Other contractual commitments relate to third-party cloud infrastructure agreements and subscription arrangements.

Future minimum payments under the Company’s non-cancelable purchase commitments as of January 31, 2023 are presented in the table below (in thousands):


	Minimum Annual Commitments
Year Ending January 31,
2024	$	13,358
2025	15,141
2026	16,881
2027	14,167
2028 and thereafter	15,084
Total	$	74,631

Legal Matters

From time to time, the Company may be a party to various legal matters, threatened claims, or proceedings in the normal course of business. Legal fees and other costs associated with such actions are expensed as incurred. The Company assesses, in conjunction with its legal counsel, the need to record a liability for litigation and contingencies. Legal accruals are recorded when and if it is determined that a loss related to a certain matter is both probable and reasonably estimable. The Company is not currently a party to any legal proceedings that, if determined adversely to it, would, in management’s opinion, have a material and adverse effect on the Company’s financial condition, results of operations, or cash flows.

Indemnification Agreements

In the ordinary course of business, the Company enters into agreements of varying scope and terms pursuant to which the Company agrees to indemnify customers, vendors, lessors and other business partners with respect to certain matters, including, but not limited to, losses arising out of the breach of such agreements, services to be provided by the Company or from intellectual property infringement claims made by third parties. Additionally, the Company entered into indemnification agreements with the Company’s directors and officers that require the Company, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as directors or officers. The Company has not incurred material costs to defend lawsuits or settle claims related to these indemnification agreements nor are we aware of any such claims that could reasonably be expected to incur material costs.

Stockholders’ Equity (Deficit) and Employee Incentive Plans

12 Months Ended

Jan. 31, 2023

Equity And Compensation Related Costs Share Based Payments [Abstract]

Stockholders’ Equity (Deficit) and Employee Incentive Plans

Redeemable Convertible Preferred Stock

Upon the closing of the Company’s IPO, all 26,710,600 shares of redeemable convertible preferred stock were automatically converted into shares of common stock, which includes an additional 640,387 shares of redeemable convertible preferred stock. The additional shares of redeemable convertible preferred stock consisted of 162,032 shares for the Series E conversion feature and 478,355 shares for the Series G dividends. The carrying value of $259.8 million was reclassified into common stock and additional paid-in-capital. As of January 31, 2023, there were no shares of redeemable convertible preferred stock issued and outstanding.

In connection with the IPO, the Company’s amended and restated certificate of incorporation became effective, which authorized the issuance of 200,000,000 shares of undesignated preferred stock with a par value of $0.00001 per share with rights and preferences, including voting rights, designated from time to time by the board of directors.

Common Stock

The Company’s Amended and Restated Certificate of Incorporation authorized the Company to issue 1,000,000,000 shares of common stock at a par value of $0.00001 as of January 31, 2023 and 2022.

Each share of common stock is entitled to one vote. The holders of common stock are also entitled to receive dividends whenever funds are legally available and when and if declared by the board of directors, subject to the prior rights of holders of all classes of stock outstanding. As of January 31, 2023 and 2022, no dividends had been declared.

As of January 31, 2023, the Company has reserved common stock for future issuance as follows:


	January 31, 2023	January 31, 2022
Stock options outstanding	7,819,480	9,167,495
Shares available for future issuance under the 2021 Plan	2,063,716	2,798,981
Restricted stock units issued and outstanding	4,502,982	1,497,558
Shares available for future issuance under the 2023 Inducement Plan	1,300,000	—
ESPP	954,159	830,000
Common stock warrants	105,350	105,350
Total	16,745,687	14,399,384

Stock Plans

The Company has four equity incentive plans: the 2008 Equity Incentive Plan (the “2008 Plan”), 2018 Equity Incentive Plan (the “2018 Plan”), 2021 Equity Incentive Plan (the “2021 Plan”) and 2023 Inducement Equity Incentive Plan (the “2023 Inducement Plan”), collectively (the “Stock Plans”). In connection with the Company’s IPO in July 2021, the 2008 Plan and the 2018 Plan were terminated and replaced by the 2021 Plan and all shares that remained available for issuance under the 2018 Plan at that time were reserved for issuance under the 2021 Plan. The number of shares of common stock available for issuance under the 2021 Plan will be increased by any shares of common stock subject to awards outstanding under the 2008 Plan and the 2018 Plan that expire or otherwise terminate without having been exercised or issued in full, are tendered to or withheld by the Company for payment of an exercise price or for satisfying tax withholding obligations or are forfeited to or repurchased by the Company due to failure to vest.

The Company has issued stock options to employees, directors, consultants and advisors pursuant to the 2018 Plan and restricted stock units (“RSUs”) under the 2021 Plan.

Equity awards permitted under the 2021 Plan may be stock options, stock appreciation rights, restricted stock, restricted stock units, performance units and performance shares. Stock option grants may be either Incentive Stock Options (“ISO”) or Non-Qualified Stock Options (“NSO”). ISO may be granted only to Company employees (including officers and directors who are also employees). NSOs may be granted to Company employees, consultants, and nonemployee directors. Employee stock options are granted with an exercise price no less than the fair value of the underlying common stock on the grant date. Options granted under the 2021 Plan expire ten years from the date of grant and generally vest over four years at a rate of 25% upon the first anniversary of the issuance date and 1/48 per month thereafter.

As of January 31, 2023, there were 2.1 million shares available for grant under the 2021 Plan. The 2021 Plan provides that the number of shares reserved will automatically increase on the first day of each fiscal year, beginning on February 1, 2022, by an amount equal to the least of (i) 4,120,000 shares, (ii) five-percent (5%) of the outstanding shares of our common stock on the last day of the immediately preceding fiscal year, or (iii) such number of shares determined by the administrator of the 2021 Plan no later than the last day of the immediately preceding Fiscal Year.

Effective January 12, 2023, the Company adopted the 2023 Inducement Equity Incentive Plan (the “2023 Inducement Plan”), pursuant to which the Company reserved 1,300,000 shares of its common stock to be used exclusively for grants of awards to individuals who were not previously employees or directors of the Company, as an inducement material to the individual’s entry into employment with the Company within the meaning of Rule 5635(c)(4) of the Nasdaq Listing Rules. The maximum number of shares of our common stock that may be issued under the 2023 Inducement Plan will not exceed 1,300,000 shares, all of which were available for future awards as of January 31, 2023. The 2023

Inducement Plan was approved by the Company’s Board of Directors without stockholder approval in accordance with such rule.

Employee Stock Purchase Plan

In July 2021, the Company established an Employee Stock Purchase Plan (“ESPP”) in which eligible employees may contribute up to 15% of their base compensation to purchase shares of common stock at a price equal to 85% of the lower of (1) the fair market value of a share of the Company’s common stock at the beginning of the offering period and (2) the fair market value of a share of the Company’s common stock on the purchase date. A participant will be permitted to purchase a maximum of shares during each offering period and no participant may purchase more than 1,000 shares during any offering period.

Except for the initial offering period, the ESPP provides for 24-month offering periods beginning March 21 and September 21 of each year, and each offering period will consist of four six-month purchase periods. The initial offering period began on July 22, 2021 and will end on September 20, 2023. The initial offering period consists of four purchase periods with the first purchase date on March 21, 2022, and the final purchase period ending on September 20, 2023.

The Company recognized stock-based compensation expense related to the ESPP of $2.0 million during the year ended January 31, 2023. As of January 31, 2023, accrued ESPP employee payroll contributions of $1.1 million are included within accrued compensation and benefits in the consolidated balance sheet. ESPP payroll contributions used to purchase shares are reclassified to stockholders’ equity on the purchase date. As of January 31, 2023, $0.7 million of unrecognized stock-based compensation expense related to the ESPP is expected to be recognized over a weighted-average vesting period of 0.6 years.

During the year ended January 31, 2023, 314,315 shares of common stock were issued under the ESPP.

Stock Options

The following table summarizes stock option activity under the Stock Plans for the year ended January 31, 2023 (aggregate intrinsic value in thousands):


	Options Outstanding
	Number of Options	Weighted- Average Exercise Price		Weighted- Average Contractual Term	Aggregate Intrinsic Value
Balances as of January 31, 2022	9,150,821	$	9.76	6.53	$	126,368
Options exercised	(801,079)	$	6.40
Options granted	—	$	—
Options cancelled	(530,262)	$	14.54
Balances as of January 31, 2023	7,819,480	$	9.78	5.21	$	51,606
Options vested and expected to vest as of January 31, 2023	7,819,480	$	9.78	5.21	$	51,606
Options vested and exercisable as of January 31, 2023	6,525,570	$	8.27	4.69	$	48,560

The weighted-average grant-date fair value of options granted during the years ended January 31, 2022 and 2021 was $9.30 and $3.18, respectively. The total intrinsic value of options exercised during the years ended January 31, 2023, 2022 and 2021 was $9.3 million, $28.2 million and $3.6 million, respectively. Aggregate intrinsic value represents the difference between the exercise price of the options and the estimated fair value of the Company’s common stock.

The Company recognized stock-based compensation expense related to stock options of $6.4 million, $7.5 million and $4.7 million, during the years ended January 31, 2023, 2022 and 2021, respectively. As of January 31, 2023, there was $8.8 million of unrecognized stock-based compensation expense related to unvested stock options, which is expected to be recognized over a weighted-average period of 1.7 years.

During the year ended January 31, 2018, in connection with services provided for recruitment, the Company granted 40,646 stock options outside of the Stock Plans to a third party. During the year ended January 31, 2023, the recipient exercised 16,674 stock options and as of January 31, 2023, the recipient had exercised all 40,646 options.

Service-Based RSUs

During the year ended January 31, 2022, the Company began granting RSUs to its employees, which have service-based vesting conditions. The service-based vesting condition for these awards is generally satisfied by rendering continuous service for four years, during which time the grants will vest quarterly.

The following table is a summary of RSU activity for the year ended January 31, 2023:


	RSUs Outstanding
	Number of RSUs	Weighted Average Grant Date Fair Value Per Share
Balances as of January 31, 2022	283,558	$	43.76
RSUs granted	4,340,172	17.80
RSUs vested	(452,477)	23.07
RSUs forfeited	(728,271)	21.84
Balances as of January 31, 2023	3,442,982	$	18.39

The aggregate grant date fair value of the RSU awards granted was $77.2 million and $13.5 million during the years ended January 31, 2023 and 2022, respectively, which represents the fair value of the common stock on the date the service-based vesting awards were granted.

We recognized $15.3 million and $1.1 million in stock-based compensation expense related to service vesting-based RSUs during the years ended January 31, 2023 and 2022, respectively. As of January 31, 2023, there was $56.9 million of unrecognized compensation expense related to service-based RSUs expected to be recognized over a weighted-average vesting period of 3.2 years.

Market-Based RSUs

During the years ended January 31, 2023 and 2022, the Board of Directors granted restricted stock unit awards with market-based vesting conditions (“Market-based RSUs”) to certain executive officers and members of senior management pursuant to the 2021 Plan. The Market-based RSUs are comprised of four tranches that vest depending on a consecutive 60-trading day stock price target of the Company’s common stock. The grant fair value of each tranche was calculated using a Monte Carlo simulation model with the following assumptions:


	Year Ended January 31,
	2023		2022
Market-based awards:
Expected term (in years)	4.7		5.0
Expected volatility	63.0	%	50.0	%
Risk-free interest rate	2.9	%	1.7	%
Dividend yield	—		—

The following is a summary of market-based RSU activity for the year ended January 31, 2023:


	RSUs Outstanding
	Number of RSUs	Weighted Average Grant Date Fair Value Per Share
Balances as of January 31, 2022	1,214,000	$	6.48
RSUs granted	14,000	$	5.30
RSUs vested	—	$	—
RSUs forfeited	(168,000)	$	6.48
Balances as of January 31, 2023	1,060,000	$	6.47

The grant date fair value of market-based RSUs was estimated at $0.1 million and $7.9 million during the years ended January 31, 2023 and 2022, respectively, and is being expensed over the requisite service period of each tranche regardless of whether the market condition is satisfied.

Stock-based compensation expense related to market-based RSUs was $2.0 million during the year ended January 31, 2023. During the year ended January 31, 2022, stock-based compensation expense related to market-based RSUs was immaterial. As of January 31, 2023, there was $4.9 million of unrecognized compensation expense related to market-based RSUs expected to be recognized over an average vesting period of 2.7 years.

Determination of Fair Value

The Company estimates the fair value of stock options and purchase rights issued to employees under the ESPP using the Black-Scholes option-pricing model, which is dependent upon several variables, such as the fair value of the Company’s common stock, the expected option term, expected volatility of the Company’s stock price over the expected term, expected risk-free interest rate over the expected option term, and expected dividend yield.

Expected term—The expected term represents the weighted-average period the stock options are expected to remain outstanding and is calculated using the simplified method, as the Company did not have sufficient historical information to develop reasonable expectations about future exercise patterns and post-vesting employment termination behavior. The simplified method calculates the expected term as the midpoint between the vesting date and the contractual expiration date of the option.

Expected volatility—The expected stock price volatility assumption was determined by examining the historical volatilities for industry peers, as the Company does not have sufficient trading history for the Company’s common stock.

Risk-free interest rate—The risk-free rate assumption is based on the U.S. Treasury instruments whose term was consistent with the expected term of the Company’s awards.

Dividend yield—The expected dividend assumption is based on the Company’s history and expectation of dividend payouts.

Fair value of underlying common stock— Prior to the Company’s IPO, the fair value was determined by the Board of Directors with input from management and contemporaneous independent third-party valuations. Subsequent to the IPO, the fair value of the Company’s common stock is based on the daily average selling price on the Nasdaq Global Select Market.

The fair value of employee stock options was estimated using the following weighted-average assumptions:


	Year Ended January 31,
	2023	2022		2021
Stock Option Plans:
Expected term (in years)	*	6.1		6.1
Expected volatility	*	42.0	%	40.0	%
Risk-free interest rate	*	1.0	%	0.4	%
Dividend yield	*	—		—

*No stock options were granted during the year ended January 31, 2023.

The fair value of employee stock purchase rights for the offering period under the ESPP was determined on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions:


	Year Ended January 31,
	2023		2022
Employee Stock Purchase Plan:
Expected term (in years)	0.9		1.0
Expected volatility	63.0	%	50.0	%
Risk-free interest rate	0.6	%	0.1	%
Dividend yield	—		—

Stock-Based Compensation

Stock-based compensation expense, net of amounts capitalized was as follows (in thousands):


	Year Ended January 31,
	2023		2022		2021
Cost of revenue—subscription	$	535	$	196	$	69
Cost of revenue—services	433		196		54
Research and development	7,937		3,343		1,316
Sales and marketing	9,426		3,968		1,536
General and administrative	7,390		3,047		1,696
Restructuring	65		—		—
Total stock-based compensation expense	$	25,786	$	10,750	$	4,671

Income Taxes

12 Months Ended

Jan. 31, 2023

Income Tax Disclosure [Abstract]

Income Taxes

The components of income (loss) before income taxes were as follows (in thousands):


	Year Ended January 31,
	2023		2022		2021
United States	$	(75,449)	$	(61,180)	$	(42,232)
International	7,993		3,966		3,293
Total	$	(67,456)	$	(57,214)	$	(38,939)

The provision for income taxes consists of the following (in thousands):


	Year Ended January 31,
	2023		2022		2021
Current
Federal	$	—	$	—	$	—
State	65		58		53
Foreign	1,459		957		991
	1,524		1,015		1,044
Deferred
Federal	—		—		—
State	—		—		—
Foreign	(486)		—		—
	(486)		—		—
Total provision for income taxes	$	1,038	$	1,015	$	1,044

The effective tax rate differs from the federal statutory income tax rate applied to the loss before provision for income taxes and tax due to the following:


	As of January 31,
	2023		2022		2021
Provision for income taxes computed at federal statutory rate	21.0	%	21.0	%	21.0	%
State taxes, net of federal benefits	4.8		5.0		13.7
Foreign rate differential	1.6		0.2		(0.3)
Stock-based compensation	(2.6)		2.0		0.1
Tax credits	2.2		2.2		(0.1)
U.S. tax on foreign earnings	(1.4)		(0.2)		1.1
Change in valuation allowance	(24.2)		(31.2)		(37.8)
Other	(2.9)		(0.8)		(0.4)
Total	(1.5)	%	(1.8)	%	(2.7)	%

Significant components of the Company’s deferred tax assets are as follows (in thousands):


	As of January 31,
	2023		2022
Deferred tax assets:
Net operating loss carryforwards	$	82,366	$	80,434
Tax credit carryforwards	15,927		13,311
Accruals and reserves	4,076		2,541
Interest carryforwards	2,344		2,873
Deferred revenue	36		776
Stock-based compensation	3,302		2,680
Capitalized research & development costs	16,352		3,882
Other	32		6
Gross deferred tax assets	$	124,435	$	106,503
Less: Valuation allowance	(117,310)		(100,983)
Total deferred tax assets	$	7,125	$	5,520
Deferred tax liabilities:
Deferred commissions	$	(4,993)	$	(4,858)
Other	(1,646)		(662)
Total deferred tax liabilities	$	(6,639)	$	(5,520)
Net deferred tax assets (liabilities)	$	486	$	—

A valuation allowance is provided when it is not more likely than not that some portion of the deferred tax assets will be realized. Management believes that, based on a number of factors, it is more likely than not that the U.S. federal and state net deferred tax assets will not be fully realized, thus a full valuation allowance has been recorded as of January 31, 2023, 2022 and 2021. A valuation allowance of $117.3 million, $101.0 million, and $83.1 million has been established by the Company as of January 31, 2023, 2022 and 2021, respectively. The change in the valuation allowance during the years ended January 31, 2023, 2022 and 2021 was an increase of $16.3 million, $17.9 million and $14.7 million, respectively, primarily due to additional losses.

As of January 31, 2023, the Company had net operating loss carryforwards of $324.4 million for U.S. federal and $178.5 million for U.S. state income tax purposes available to offset future taxable income. Of the Company’s U.S. federal NOLs, no amount may be carried forward indefinitely with no limitations when utilized, and $155.6 million may be carried forward indefinitely with utilization limited to 80% of taxable income. The remaining $168.8 million will begin to expire in 2028. The Company’s state NOLs carryforwards begin to expire in 2026.. As of January 31, 2023, the Company had federal and state research and development credits of $13.8 million and $12.6 million, respectively. The federal research and development credits will begin expiring in 2029. The state research and development credits are not currently subject to expiration. Utilization of the net operating loss and tax credit carryforwards may be subject to annual limitation due to

the ownership change limitations provided by the Code and similar state provisions. Such an annual limitation could result in the expiration of net operating loss and tax credit carryforwards before utilization.

Foreign withholding taxes have not been provided for the cumulative undistributed earnings of the Company’s foreign subsidiaries as of January 31, 2023 due to the Company’s intention to permanently reinvest such earnings. Determination of the amount of unrecognized deferred tax liability related to these earnings is not reasonably practicable.

The following table shows the changes in the gross unrecognized tax benefits (in thousands):


	Year Ended January 31,
	2023		2022		2021
Beginning balance	$	8,835	$	7,162	$	3,601
Increase related to current year tax positions	1,744		1,673		1,401
Increase related to prior year tax positions	—		—		2,160
Ending balance	$	10,579	$	8,835	$	7,162

As of January 31, 2023, 2022 and 2021, no amount of unrecognized tax benefits, if recognized, would impact the Company’s effective tax rate.

There were no interest and penalties associated with unrecognized income tax benefits for the years ended January 31, 2023, 2022 and 2021.

Although it is reasonably possible that certain unrecognized tax benefits may increase or decrease within the next 12 months due to tax examination changes, settlement activities or the impact on recognition and measurement considerations related to the results of published tax cases or other similar activities, the Company does not anticipate any significant changes to unrecognized tax benefits over the next 12 months.

The Company files income tax returns in the U.S. federal jurisdiction, various state and local jurisdictions and in various international jurisdictions. Due to the Company’s net operating loss carryforwards, all tax years since inception remain subject to examination by U.S. federal and state taxing authorities. Tax years 2015 and forward generally remain open for examination for foreign tax purposes.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 21
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-URI https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 17
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.5.Q1)
-URI https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 14
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 270
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-URI https://asc.fasb.org/topic&trid=2144680

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

+ Details

Restructuring

12 Months Ended

Jan. 31, 2023

Restructuring and Related Activities [Abstract]

Restructuring

During the fourth quarter of the fiscal year ended January 31, 2023, the Company initiated a restructuring plan to improve operational efficiency. This resulted in severance costs and related costs and stock-based compensation related to modifications of vested awards granted to certain employees impacted by the restructuring plan.

Restructuring expense was as follows (in thousands):


			Year Ended January 31, 2023
Employee severance and related costs			1,598
Stock-based compensation			65
Total restructuring charges			1,663

Restructuring Liabilities

Restructuring liabilities are reported within accrued expenses in the Consolidated Balance Sheets. The balance as of January 31, 2023 of $1.6 million is comprised of employee severance and related costs. An immaterial amount was paid during the year ended January 31, 2023.

Geographic Information

12 Months Ended

Jan. 31, 2023

Segment Reporting [Abstract]

Geographic Information

The following table depicts the disaggregation of revenue by geographic area based on the billing address of the customer (in thousands):


	Year Ended January 31,
	2023		2022		2021

United States	$	95,762	$	77,074	$	66,737
International	59,062		46,468		36,548
Total	$	154,824	$	123,542	$	103,285

No individual foreign country contributed 10% or more of total revenue for the years ended January 31, 2023, 2022 and 2021.

As of January 31, 2023 and 2022, the majority of the Company’s long-lived assets, including operating lease ROU assets were located in the United States.

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 15
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-URI https://asc.fasb.org/topic&trid=2134510

+ Details

Net Loss per Share

12 Months Ended

Jan. 31, 2023

Earnings Per Share [Abstract]

Net Loss per Share

Basic net loss per share attributable to the Company’s common stockholders is computed by dividing the net loss attributable to the Company’s common stockholders by the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share is the same as basic net loss per share for all years presented because the effects of potentially dilutive items were anti-dilutive given the Company’s net loss position in each period presented.

The following table presents the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share data):


	Year Ended January 31,
	2023		2022		2021
Numerator
Net loss	$	(68,494)	$	(58,229)	$	(39,983)
Cumulative dividends on Series G redeemable convertible preferred stock	—		(2,917)		(4,076)
Net loss attributable to common stockholders	$	(68,494)	$	(61,146)	$	(44,059)
Denominator
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted	44,787		25,777		5,717
Net loss per share attributable to common stockholders, basic and diluted	$	(1.53)	$	(2.37)	$	(7.71)

The following potentially dilutive securities were excluded from the computation of diluted net loss per share for the periods presented because the impact of including them would have been anti-dilutive (in thousands):


	Year Ended January 31,
	2023	2022	2021
Stock options	7,819	9,167	8,912
RSUs	4,499	1,498	—
Employee stock purchase rights under the ESPP	130	231	—
Common stock warrants	105	105	105
Redeemable convertible preferred stock (on an if-converted basis)	—	—	26,513
Total	12,553	11,001	35,530

Subsequent Events	12 Months Ended
Subsequent Events	Jan. 31, 2023
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events Silicon Valley Bank On March 10, 2023, Silicon Valley Bank (“SVB”) was closed by the California Department of Financial Protection and Innovation, and the Federal Deposit Insurance Corporation (“FDIC”) was appointed as receiver. Thereafter, the FDIC transferred all deposits of SVB to a newly created bridge bank, named Silicon Valley Bridge Bank, N.A. (“SVBB”), providing all depositors access to their money beginning on March 13, 2023. On March 26, 2023, the FDIC announced that it had entered into a purchase and assumption agreement for all deposits and loans of SVBB by First-Citizens Bank & Trust Company, Raleigh, North Carolina. The Company maintains certain operating accounts and has an undrawn revolving credit facility with the former SVB. The remainder of the Company’s cash, cash equivalents and short-term investments are held at other financial institutions or third-party custodians. The Company believes that its potential exposure to any loss related to its accounts with the former SVB would not be material. Modification of Market-Based Awards On March 20, 2023, the Board of Directors approved a modification of the Company’s 1,060,000 outstanding Market-based RSUs granted to certain executive officers and members of senior management. The 840,000 awards granted to certain executive officers were modified from market-based vesting conditions to performance-based vesting conditions and will vest based on the Company achieving certain financial metrics over revised service periods. As of the modification date, total incremental stock-based compensation is approximately $6.0 million to be recognized over the revised service periods. The 220,000 awards granted to certain members of senior management were modified to revise the 60-trading day stock price target of the Company’s common stock and the requisite service periods. As of the modification date, total incremental stock-based compensation is approximately $1.4 million to be recognized over the revised service periods.

Basis of Presentation and Summary of Significant Accounting Policies (Policies)

12 Months Ended

Jan. 31, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation

Fiscal Year

The Company’s fiscal year ends on January 31. References to fiscal 2023, 2022 and 2021 refer to the years ended January 31, 2023, 2022 and 2021, respectively.

Segment Information

Use of Estimates

Foreign Currency

Foreign CurrencyThe reporting currency of the Company is the United States dollar (“U.S. dollar”). The functional currency of each of the Company’s foreign subsidiaries is the U.S. dollar. Accordingly, each foreign subsidiary remeasures monetary assets and liabilities at period-end exchange rates, while nonmonetary items are remeasured at historical rates. Revenue and expense items are remeasured at the exchange rates in effect on the day the transaction occurred, except for those expenses related to non-monetary assets and liabilities, which are remeasured at historical exchange rates. Remeasurement adjustments are recognized in other income (expense), net in the consolidated statements of operations.

Revenue Recognition

The Company accounts for revenue in accordance with Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers (“ASC 606”).

Revenue is derived from sales of subscriptions and services.

The Company determines revenue recognition in accordance with ASC 606 through the following five steps:

Allocation of Overhead Costs

Cost of Revenue

Deferred Commissions

Deferred Revenue

Advertising

Stock-Based Compensation

Income Taxes

The Company is subject to income taxes in the United States and certain foreign jurisdictions.

Net Loss Per Share Attributable to Common Stockholders

Cash and Cash Equivalents

The Company considers all highly liquid investments with original or remaining maturities of three months or less when purchased to be cash and cash equivalents.

Restricted Cash

Short-Term Investments

Accounts Receivable

Concentration of Credit Risk

Fair Value of Financial Instruments

Level 1: Observable inputs, such as quoted prices in active markets for identical assets or liabilities.

Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

Property and Equipment, Net


Computer equipment			3 years
Furniture and fixtures			5 years
Leasehold improvements			Shorter of lease term or estimated useful life
Capitalized internal-use software			3 years

Capitalized Internal-Use Software

Lessor, Leases

Leases

Impairment of Long-Lived Assets

Recent Accounting Pronouncements

Accounting Pronouncements Recently Adopted

Accounting Pronouncements Not Yet Adopted

Fair Value Measurements

Level 1: Observable inputs, such as quoted prices in active markets for identical assets or liabilities.

Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

Basis of Presentation and Summary of Significant Accounting Policies (Tables)

12 Months Ended

Jan. 31, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Changes in the Allowance for Doubtful Accounts

The following table presents the changes in the allowance for doubtful accounts (in thousands):


	Year Ended January 31,
	2023		2022		2021
Beginning balance	$	108	$	73	$	81
Add: bad debt expense	69		41		84
Less: write-offs, net of recoveries	(4)		(6)		(92)
Ending balance	$	173	$	108	$	73

Schedule of Property and Equipment


Computer equipment			3 years
Furniture and fixtures			5 years
Leasehold improvements			Shorter of lease term or estimated useful life
Capitalized internal-use software			3 years

Property and equipment, net consisted of the following (in thousands):


	As of January 31,
	2023		2022
Computer equipment	$	3,586	$	3,711
Furniture and fixtures	342		412
Capitalized internal-use software	7,884		5,772
Leasehold improvements	1,889		1,582

Construction in progress—capitalized internal-use software	3,395		—
Total gross property and equipment	17,096		11,477
Accumulated depreciation and amortization	(9,666)		(7,189)
Total property and equipment, net	$	7,430	$	4,288

Cash Equivalents and Short-Term Investments (Tables)

12 Months Ended

Jan. 31, 2023

Cash and Cash Equivalents [Abstract]

Summary of Cash Equivalents and Short-term Investments

The following tables summarize the Company’s cash equivalents and short-term investments (in thousands):


	As of January 31, 2023
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value
Cash Equivalents
Money market funds	$	29,239	$	—	$	—	$	29,239
Corporate debt securities	1,122		—		—		1,122
Total cash equivalents	30,361		—		—		30,361
Short-Term Investments
U.S. government treasury securities	71,981		1		(729)		71,253
Commercial paper	31,500		—		—		31,500
Corporate debt securities	11,952		—		(50)		11,902
U.S. government agency securities	7,839		3		(1)		7,841
Asset-backed securities	5,391		—		(31)		5,360
Total short-term investments	128,663		4		(811)		127,856
Total	$	159,024	$	4	$	(811)	$	158,217


	As of January 31, 2022
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value
Cash Equivalents
Money market funds	$	86,505	$	—	$	—	$	86,505
Total cash equivalents	86,505		—		—		86,505
Short-Term Investments
U.S. government treasury securities	39,340		—		(129)		39,211
Commercial paper	40,966		—		(1)		40,965
Corporate debt securities	30,156		—		(66)		30,090
Total short-term investments	110,462		—		(196)		110,266
Total	$	196,967	$	—	$	(196)	$	196,771

Summary of Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value


	As of January 31, 2023
	Less Than 12 Months				12 Months or Greater				Total
	Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value
U.S. government treasury securities	$	(729)	$	64,397	$	—	$	—	$	(729)	$	64,397
Corporate debt securities	(49)		8,909		(1)		1,999		(50)		10,908
U.S. government agency securities	(1)		1,918		—		—		(1)		1,918
Asset-backed securities	(31)		5,359		—		—		(31)		5,359
Total	$	(810)	$	80,583	$	(1)	$	1,999	$	(811)	$	82,582


	As of January 31, 2022
	Less Than 12 Months				12 Months or Greater				Total
	Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value
U.S. government treasury securities	$	(129)	$	39,211	$	—	$	—	$	(129)	$	39,211
Commercial paper	(1)		2,497		—		—		(1)		2,497
Corporate debt securities	(66)		30,090		—		—		(66)		30,090
Total	$	(196)	$	71,798	$	—	$	—	$	(196)	$	71,798

Fair Value Measurements (Tables)

12 Months Ended

Jan. 31, 2023

Fair Value Disclosures [Abstract]

Schedule of Fair Value Hierarchy For Company's Assets Measured at Fair Value on Recurring Basis

The following tables present the fair value hierarchy for the Company’s assets measured at fair value on a recurring basis (in thousands):


	As of January 31, 2023
	Level 1		Level 2		Total
Cash Equivalents
Money market funds	$	29,239	$	—	$	29,239
Corporate debt securities	—		1,122		1,122
Total cash equivalents	29,239		1,122		30,361
Short-Term Investments
U.S. government treasury securities	—		71,253		71,253
Commercial paper	—		31,500		31,500
Corporate debt securities	—		11,902		11,902
U.S. government agency securities	—		7,841		7,841
Asset-backed securities	—		5,360		5,360
Total short-term investments	—		127,856		127,856
Total	$	29,239	$	128,978	$	158,217


	As of January 31, 2022
	Level 1		Level 2		Total
Cash Equivalents
Money market funds	$	86,505	$	—	$	86,505
Total cash equivalents	86,505		—		86,505
Short-Term Investments
U.S. government treasury securities	—		39,211		39,211
Commercial paper	—		40,965		40,965
Corporate debt securities	—		30,090		30,090
Total short-term investments	—		110,266		110,266
Total	$	86,505	$	110,266	$	196,771

Balance Sheet Components (Tables)

12 Months Ended

Jan. 31, 2023

Balance Sheet Related Disclosures [Abstract]

Schedule of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in thousands):


	As of January 31,
	2023		2022
Prepaid expenses	$	4,140	$	4,518
Prepaid software	2,560		2,297
Other current assets	1,534		1,744
Total prepaid expenses and other current assets	$	8,234	$	8,559

Schedule of Property and Equipment


Computer equipment			3 years
Furniture and fixtures			5 years
Leasehold improvements			Shorter of lease term or estimated useful life
Capitalized internal-use software			3 years

Property and equipment, net consisted of the following (in thousands):


	As of January 31,
	2023		2022
Computer equipment	$	3,586	$	3,711
Furniture and fixtures	342		412
Capitalized internal-use software	7,884		5,772
Leasehold improvements	1,889		1,582

Construction in progress—capitalized internal-use software	3,395		—
Total gross property and equipment	17,096		11,477
Accumulated depreciation and amortization	(9,666)		(7,189)
Total property and equipment, net	$	7,430	$	4,288

Schedule of Accrued Compensation and Benefits

Accrued compensation and benefits consisted of the following (in thousands):


	As of January 31,
	2023		2022
Accrued bonus	$	5,944	$	5,557
Accrued commissions	3,593		4,226
Accrued payroll and benefits	1,995		2,863
Employee contributions under the ESPP	1,109		3,497
Total accrued compensation and benefits	$	12,641	$	16,143

Schedule of Other Accrued Liabilities

Other accrued liabilities consisted of the following (in thousands):


	As of January 31,
	2023		2022
Accrued professional fees	$	1,020	$	717
Sales and value added tax payable	737		671
Income taxes payable	743		414
Accrued restructuring	1,567		—
Other	2,009		1,429
Total other accrued liabilities	$	6,076	$	3,231

Deferred Revenue and Remaining Performance Obligations (Tables)

12 Months Ended

Jan. 31, 2023

Revenue from Contract with Customer [Abstract]

Schedule of Deferred Revenue Balances and Changes in Deferred Revenues Balances

The following table presents the deferred revenue balances (in thousands):


	As of January 31,
	2023		2022

Deferred revenue, current	$	71,716	$	69,010
Deferred revenue, noncurrent	3,275		2,713
Total deferred revenue	$	74,991	$	71,723

Changes in the deferred revenue balances during the years ended January 31, 2023 and 2022 were as follows (in thousands):


	Year Ended January 31,
	2023		2022

Beginning balance	$	71,723	$	61,710
Performance obligations satisfied during the period that were included in the deferred revenue balance at the beginning of the year	(66,480)		(57,809)
Increases due to invoicing prior to satisfaction of performance obligations	69,748		67,822
Ending balance	$	74,991	$	71,723

Leases (Tables)

12 Months Ended

Jan. 31, 2023

Leases [Abstract]

Schedule of Supplemental Cash Flow Related to Leases

The following table presents supplemental cash flow information related to leases (in thousands):


	Year Ended January 31, 2023
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash outflows from operating leases	$	3,169
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$	2,811

Schedule of Supplemental Balance Sheet Information

The following table presents supplemental balance sheet information related to operating leases (in thousands, except for lease term and discount rate):


	As of January 31, 2023
Operating lease right-of-use assets	$	6,940
Operating lease liabilities	$	3,117
Operating lease liabilities, noncurrent	4,543
Total operating lease liabilities	$	7,660
Weighted-average remaining lease term	2.7 years
Weighted-average discount rate	3.8		%

Schedule of Operating Lease Maturities

As of January 31, 2023, remaining maturities of operating lease liabilities were as follows (in thousands):


Period	Operating Leases
Fiscal 2024	$	3,309
Fiscal 2025	2,975
Fiscal 2026	1,172
Fiscal 2027	352
Fiscal 2028 and thereafter	251
Total lease payments	8,059
Less: imputed interest	(399)
Total	$	7,660

Schedule of Future Net Minimum Lease Payments

Future minimum lease payments under non-cancelable operating leases as of January 31, 2022 under ASC 840 were as follows (in thousands):


Year Ending January 31,	Operating Leases
2023	$	2,845
2024	2,638
2025	2,178
2026	362
2027 and thereafter	—
Total	$	8,023

Commitments and Contingencies (Tables)

12 Months Ended

Jan. 31, 2023

Commitments and Contingencies Disclosure [Abstract]

Schedule of Future Minimum Payments Non-cancelable Purchase Commitments

Future minimum payments under the Company’s non-cancelable purchase commitments as of January 31, 2023 are presented in the table below (in thousands):


	Minimum Annual Commitments
Year Ending January 31,
2024	$	13,358
2025	15,141
2026	16,881
2027	14,167
2028 and thereafter	15,084
Total	$	74,631

Stockholders’ Equity (Deficit) and Employee Incentive Plans (Tables)

12 Months Ended

Jan. 31, 2023

Equity And Compensation Related Costs Share Based Payments [Abstract]

Summary of Reserved Common Stock for Future Issuance

As of January 31, 2023, the Company has reserved common stock for future issuance as follows:


	January 31, 2023	January 31, 2022
Stock options outstanding	7,819,480	9,167,495
Shares available for future issuance under the 2021 Plan	2,063,716	2,798,981
Restricted stock units issued and outstanding	4,502,982	1,497,558
Shares available for future issuance under the 2023 Inducement Plan	1,300,000	—
ESPP	954,159	830,000
Common stock warrants	105,350	105,350
Total	16,745,687	14,399,384

Summary of Stock Option Activity under Stock Plans

The following table summarizes stock option activity under the Stock Plans for the year ended January 31, 2023 (aggregate intrinsic value in thousands):


	Options Outstanding
	Number of Options	Weighted- Average Exercise Price		Weighted- Average Contractual Term	Aggregate Intrinsic Value
Balances as of January 31, 2022	9,150,821	$	9.76	6.53	$	126,368
Options exercised	(801,079)	$	6.40
Options granted	—	$	—
Options cancelled	(530,262)	$	14.54
Balances as of January 31, 2023	7,819,480	$	9.78	5.21	$	51,606
Options vested and expected to vest as of January 31, 2023	7,819,480	$	9.78	5.21	$	51,606
Options vested and exercisable as of January 31, 2023	6,525,570	$	8.27	4.69	$	48,560

Share-based Payment Arrangement, Restricted Stock Unit, Activity

The following table is a summary of RSU activity for the year ended January 31, 2023:


	RSUs Outstanding
	Number of RSUs	Weighted Average Grant Date Fair Value Per Share
Balances as of January 31, 2022	283,558	$	43.76
RSUs granted	4,340,172	17.80
RSUs vested	(452,477)	23.07
RSUs forfeited	(728,271)	21.84
Balances as of January 31, 2023	3,442,982	$	18.39

The following is a summary of market-based RSU activity for the year ended January 31, 2023:


	RSUs Outstanding
	Number of RSUs	Weighted Average Grant Date Fair Value Per Share
Balances as of January 31, 2022	1,214,000	$	6.48
RSUs granted	14,000	$	5.30
RSUs vested	—	$	—
RSUs forfeited	(168,000)	$	6.48
Balances as of January 31, 2023	1,060,000	$	6.47

Schedule of Share-based Payment Award, Restricted Stock Units, Valuation Assumptions

The grant fair value of each tranche was calculated using a Monte Carlo simulation model with the following assumptions:


	Year Ended January 31,
	2023		2022
Market-based awards:
Expected term (in years)	4.7		5.0
Expected volatility	63.0	%	50.0	%
Risk-free interest rate	2.9	%	1.7	%
Dividend yield	—		—

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The fair value of employee stock options was estimated using the following weighted-average assumptions:


	Year Ended January 31,
	2023	2022		2021
Stock Option Plans:
Expected term (in years)	*	6.1		6.1
Expected volatility	*	42.0	%	40.0	%
Risk-free interest rate	*	1.0	%	0.4	%
Dividend yield	*	—		—

*No stock options were granted during the year ended January 31, 2023.

Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions


	Year Ended January 31,
	2023		2022
Employee Stock Purchase Plan:
Expected term (in years)	0.9		1.0
Expected volatility	63.0	%	50.0	%
Risk-free interest rate	0.6	%	0.1	%
Dividend yield	—		—

Schedule of Stock-Based Compensation Expense

Stock-based compensation expense, net of amounts capitalized was as follows (in thousands):


	Year Ended January 31,
	2023		2022		2021
Cost of revenue—subscription	$	535	$	196	$	69
Cost of revenue—services	433		196		54
Research and development	7,937		3,343		1,316
Sales and marketing	9,426		3,968		1,536
General and administrative	7,390		3,047		1,696
Restructuring	65		—		—
Total stock-based compensation expense	$	25,786	$	10,750	$	4,671

Income Taxes (Tables)

12 Months Ended

Jan. 31, 2023

Income Tax Disclosure [Abstract]

Schedule of Income Before Income Taxes

The components of income (loss) before income taxes were as follows (in thousands):


	Year Ended January 31,
	2023		2022		2021
United States	$	(75,449)	$	(61,180)	$	(42,232)
International	7,993		3,966		3,293
Total	$	(67,456)	$	(57,214)	$	(38,939)

Schedule of Income Tax Expense

The provision for income taxes consists of the following (in thousands):


	Year Ended January 31,
	2023		2022		2021
Current
Federal	$	—	$	—	$	—
State	65		58		53
Foreign	1,459		957		991
	1,524		1,015		1,044
Deferred
Federal	—		—		—
State	—		—		—
Foreign	(486)		—		—
	(486)		—		—
Total provision for income taxes	$	1,038	$	1,015	$	1,044

Schedule of Effective Income Tax Rate Reconciliation

The effective tax rate differs from the federal statutory income tax rate applied to the loss before provision for income taxes and tax due to the following:


	As of January 31,
	2023		2022		2021
Provision for income taxes computed at federal statutory rate	21.0	%	21.0	%	21.0	%
State taxes, net of federal benefits	4.8		5.0		13.7
Foreign rate differential	1.6		0.2		(0.3)
Stock-based compensation	(2.6)		2.0		0.1
Tax credits	2.2		2.2		(0.1)
U.S. tax on foreign earnings	(1.4)		(0.2)		1.1
Change in valuation allowance	(24.2)		(31.2)		(37.8)
Other	(2.9)		(0.8)		(0.4)
Total	(1.5)	%	(1.8)	%	(2.7)	%

Schedule of Deferred Tax Assets

Significant components of the Company’s deferred tax assets are as follows (in thousands):


	As of January 31,
	2023		2022
Deferred tax assets:
Net operating loss carryforwards	$	82,366	$	80,434
Tax credit carryforwards	15,927		13,311
Accruals and reserves	4,076		2,541
Interest carryforwards	2,344		2,873
Deferred revenue	36		776
Stock-based compensation	3,302		2,680
Capitalized research & development costs	16,352		3,882
Other	32		6
Gross deferred tax assets	$	124,435	$	106,503
Less: Valuation allowance	(117,310)		(100,983)
Total deferred tax assets	$	7,125	$	5,520
Deferred tax liabilities:
Deferred commissions	$	(4,993)	$	(4,858)
Other	(1,646)		(662)
Total deferred tax liabilities	$	(6,639)	$	(5,520)
Net deferred tax assets (liabilities)	$	486	$	—

Schedule of Unrecognized Tax Benefits

The following table shows the changes in the gross unrecognized tax benefits (in thousands):


	Year Ended January 31,
	2023		2022		2021
Beginning balance	$	8,835	$	7,162	$	3,601
Increase related to current year tax positions	1,744		1,673		1,401
Increase related to prior year tax positions	—		—		2,160
Ending balance	$	10,579	$	8,835	$	7,162

Restructuring (Tables)

12 Months Ended

Jan. 31, 2023

Restructuring and Related Activities [Abstract]

Schedule of Restructuring Expense

Restructuring expense was as follows (in thousands):


			Year Ended January 31, 2023
Employee severance and related costs			1,598
Stock-based compensation			65
Total restructuring charges			1,663

Geographic Information (Tables)

12 Months Ended

Jan. 31, 2023

Segment Reporting [Abstract]

Schedule of Disaggregation of Revenue by Geographic Area

The following table depicts the disaggregation of revenue by geographic area based on the billing address of the customer (in thousands):


	Year Ended January 31,
	2023		2022		2021

United States	$	95,762	$	77,074	$	66,737
International	59,062		46,468		36,548
Total	$	154,824	$	123,542	$	103,285

Net Loss per Share (Tables)

12 Months Ended

Jan. 31, 2023

Earnings Per Share [Abstract]

Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders

The following table presents the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share data):


	Year Ended January 31,
	2023		2022		2021
Numerator
Net loss	$	(68,494)	$	(58,229)	$	(39,983)
Cumulative dividends on Series G redeemable convertible preferred stock	—		(2,917)		(4,076)
Net loss attributable to common stockholders	$	(68,494)	$	(61,146)	$	(44,059)
Denominator
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted	44,787		25,777		5,717
Net loss per share attributable to common stockholders, basic and diluted	$	(1.53)	$	(2.37)	$	(7.71)

Schedule of Potentially Dilutive Securities Were Excluded From The Computation of Diluted Net Loss Per Share


	Year Ended January 31,
	2023	2022	2021
Stock options	7,819	9,167	8,912
RSUs	4,499	1,498	—
Employee stock purchase rights under the ESPP	130	231	—
Common stock warrants	105	105	105
Redeemable convertible preferred stock (on an if-converted basis)	—	—	26,513
Total	12,553	11,001	35,530

Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Details)		1 Months Ended		12 Months Ended
	Jul. 26, 2021 shares	Jul. 31, 2021 USD ($) $ / shares shares	Jun. 30, 2021	Jan. 31, 2023 USD ($) customer shares	Jan. 31, 2022 USD ($)	Jan. 31, 2021 USD ($)	Feb. 01, 2022 USD ($)
Basis Of Presentation And Summary Of Significant Accounting Policies
Consideration received on transaction		$ 214,900,000
Conversion of convertible securities (in shares) \| shares		26,710,600,000,000
Preferred stock and dividend features converted into common stock (in shares) \| shares		640,387,000,000
Foreign currency transaction gain (loss)				$ (500,000)	$ (400,000)	$ 900,000
Advertising costs				0	0	0
Accounts receivable, net				0	0
Impairment of long-lived assets				$ 0	0	0
Expected future revenue stream of benefit, period				3 years
Deferred sales commission, impairment loss				$ 0	0	$ 0
Operating lease right-of-use assets				6,940,000	$ 0		$ 6,700,000
Operating lease, liability				$ 7,660,000			7,500,000
Deferred rent credit							$ 800,000
Revenue Benchmark \| Customer Concentration Risk \| Customer A
Basis Of Presentation And Summary Of Significant Accounting Policies
Concentration risk, percentage				10.00%	10.00%	10.00%
Accounts Receivable \| Customer Concentration Risk \| Customer A
Basis Of Presentation And Summary Of Significant Accounting Policies
Concentration risk, percentage				12.00%
Number of customers \| customer				1
Minimum
Basis Of Presentation And Summary Of Significant Accounting Policies
Intangible asset, useful life				1 year
Maximum
Basis Of Presentation And Summary Of Significant Accounting Policies
Intangible asset, useful life				3 years
Common Stock
Basis Of Presentation And Summary Of Significant Accounting Policies
Reverse stock split of outstanding common stock			2.5
IPO
Basis Of Presentation And Summary Of Significant Accounting Policies
Number of common stock for sale and issuance (in shares) \| shares		9,589,999,000,000		0
Common stock public offering price per share (in dollar per share) \| $ / shares		$ 24,000,000.00
Conversion of convertible securities (in shares) \| shares	26,710,600
Over-Allotment Option
Basis Of Presentation And Summary Of Significant Accounting Policies
Number of common stock for sale and issuance (in shares) \| shares		1,250,869,000,000

Basis of Presentation and Summary of Significant Accounting Policies - Summary of Account Receivables, Net of Allowance for Doubtful Accounts (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Accounts Receivable, Allowance for Credit Loss
Beginning balance	$ 108	$ 73	$ 81
Add: bad debt expense	69	41	84
Less: write-offs, net of recoveries	(4)	(6)	(92)
Ending balance	$ 173	$ 108	$ 73

Basis of Presentation and Summary of Significant Accounting Policies - Property and Equipment, Net (Details)	12 Months Ended
	Jan. 31, 2023
Computer equipment
Property, Plant and Equipment
Property, plant and equipment, useful life	3 years
Furniture and fixtures
Property, Plant and Equipment
Property, plant and equipment, useful life	5 years
Capitalized internal-use software
Property, Plant and Equipment
Property, plant and equipment, useful life	3 years

Cash Equivalents and Short-Term Investments - Summary of Cash Equivalents and Short-term Investments (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jan. 31, 2022
Cash and Cash Equivalents
Cash equivalents, amortized cost	$ 30,361	$ 86,505
Cash equivalents, estimated fair value	30,361	86,505
Short-Term Investments
Amortized Cost	128,663	110,462
Gross Unrealized Gains	4	0
Gross Unrealized Losses	(811)	(196)
Estimated Fair Value	127,856	110,266
Amortized Cost	159,024	196,967
Estimated Fair Value	158,217	196,771
U.S. government treasury securities
Short-Term Investments
Amortized Cost	71,981	39,340
Gross Unrealized Gains	1	0
Gross Unrealized Losses	(729)	(129)
Estimated Fair Value	71,253	39,211
Commercial paper
Short-Term Investments
Amortized Cost	31,500	40,966
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	(1)
Estimated Fair Value	31,500	40,965
Corporate debt securities
Short-Term Investments
Amortized Cost	11,952	30,156
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(50)	(66)
Estimated Fair Value	11,902	30,090
U.S. government agency securities
Short-Term Investments
Amortized Cost	7,839
Gross Unrealized Gains	3
Gross Unrealized Losses	(1)
Estimated Fair Value	7,841
Asset-backed securities
Short-Term Investments
Amortized Cost	5,391
Gross Unrealized Gains	0
Gross Unrealized Losses	(31)
Estimated Fair Value	5,360
Money market funds
Cash and Cash Equivalents
Cash equivalents, amortized cost	29,239	86,505
Cash equivalents, estimated fair value	29,239	$ 86,505
Corporate debt securities
Cash and Cash Equivalents
Cash equivalents, amortized cost	1,122
Cash equivalents, estimated fair value	$ 1,122

Cash Equivalents and Short-Term Investments - Summary of Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jan. 31, 2022
Debt Securities, Available-for-Sale, Unrealized Loss Position [Abstract]
Short-term investments, less than 12 months, unrealized Losses	$ (810)	$ (196)
Short-term investments, less than 12 months, fair value	80,583	71,798
Short-term investments,12 months or greater, unrealized Losses	(1)	0
Short-term investments, 12 months or greater, fair value	1,999	0
Short-term investments, unrealized Losses	(811)	(196)
Short-term investments, fair value	82,582	71,798
U.S. government treasury securities
Debt Securities, Available-for-Sale, Unrealized Loss Position [Abstract]
Short-term investments, less than 12 months, unrealized Losses	(729)	(129)
Short-term investments, less than 12 months, fair value	64,397	39,211
Short-term investments,12 months or greater, unrealized Losses	0	0
Short-term investments, 12 months or greater, fair value	0	0
Short-term investments, unrealized Losses	(729)	(129)
Short-term investments, fair value	64,397	39,211
Commercial paper
Debt Securities, Available-for-Sale, Unrealized Loss Position [Abstract]
Short-term investments, less than 12 months, unrealized Losses		(1)
Short-term investments, less than 12 months, fair value		2,497
Short-term investments,12 months or greater, unrealized Losses		0
Short-term investments, 12 months or greater, fair value		0
Short-term investments, unrealized Losses		(1)
Short-term investments, fair value		2,497
Corporate debt securities
Debt Securities, Available-for-Sale, Unrealized Loss Position [Abstract]
Short-term investments, less than 12 months, unrealized Losses	(49)	(66)
Short-term investments, less than 12 months, fair value	8,909	30,090
Short-term investments,12 months or greater, unrealized Losses	(1)	0
Short-term investments, 12 months or greater, fair value	1,999	0
Short-term investments, unrealized Losses	(50)	(66)
Short-term investments, fair value	10,908	$ 30,090
U.S. government agency securities
Debt Securities, Available-for-Sale, Unrealized Loss Position [Abstract]
Short-term investments, less than 12 months, unrealized Losses	(1)
Short-term investments, less than 12 months, fair value	1,918
Short-term investments,12 months or greater, unrealized Losses	0
Short-term investments, 12 months or greater, fair value	0
Short-term investments, unrealized Losses	(1)
Short-term investments, fair value	1,918
Asset-backed securities
Debt Securities, Available-for-Sale, Unrealized Loss Position [Abstract]
Short-term investments, less than 12 months, unrealized Losses	(31)
Short-term investments, less than 12 months, fair value	5,359
Short-term investments,12 months or greater, unrealized Losses	0
Short-term investments, 12 months or greater, fair value	0
Short-term investments, unrealized Losses	(31)
Short-term investments, fair value	$ 5,359

Cash Equivalents and Short Term Investments - Additional Information (Details)	12 Months Ended
	Jan. 31, 2023 USD ($) investment	Jan. 31, 2022 USD ($) investment	Jan. 31, 2021 USD ($)
Cash and Cash Equivalents [Abstract]
Reclassify from accumulated other comprehensive income (loss)	$ 0	$ 0	$ 0
Contractual maturity in one year	122,000,000	108,300,000
Contractual maturity greater than one year	$ 5,900,000	$ 2,000,000
Number of short-term investments in unrealized loss position \| Investment \| investment	27	25
Impairment of short-term investments	$ 0	$ 0	$ 0

Fair Value Measurements - Fair Value Hierarchy For Company's Assets Measured at Fair Value on Recurring Basis (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jan. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Total cash equivalents	$ 30,361	$ 86,505
Total short-term investments	127,856	110,266
U.S. government treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Total short-term investments	71,253	39,211
Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Total short-term investments	31,500	40,965
Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Total short-term investments	11,902	30,090
U.S. government agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Total short-term investments	7,841
Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Total short-term investments	5,360
Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Total cash equivalents	29,239	86,505
Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Total cash equivalents	1,122
Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Total cash equivalents	30,361	86,505
Total short-term investments	127,856	110,266
Total	158,217	196,771
Fair Value, Recurring \| U.S. government treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Total short-term investments	71,253	39,211
Fair Value, Recurring \| Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Total short-term investments	31,500	40,965
Fair Value, Recurring \| Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Total short-term investments	11,902	30,090
Fair Value, Recurring \| U.S. government agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Total short-term investments	7,841
Fair Value, Recurring \| Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Total short-term investments	5,360
Fair Value, Recurring \| Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Total cash equivalents	29,239	86,505
Total short-term investments	0	0
Total	29,239	86,505
Fair Value, Recurring \| Level 1 \| U.S. government treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Total short-term investments	0	0
Fair Value, Recurring \| Level 1 \| Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Total short-term investments	0	0
Fair Value, Recurring \| Level 1 \| Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Total short-term investments	0	0
Fair Value, Recurring \| Level 1 \| U.S. government agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Total short-term investments	0
Fair Value, Recurring \| Level 1 \| Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Total short-term investments	0
Fair Value, Recurring \| Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Total cash equivalents	1,122	0
Total short-term investments	127,856	110,266
Total	128,978	110,266
Fair Value, Recurring \| Level 2 \| U.S. government treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Total short-term investments	71,253	39,211
Fair Value, Recurring \| Level 2 \| Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Total short-term investments	31,500	40,965
Fair Value, Recurring \| Level 2 \| Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Total short-term investments	11,902	30,090
Fair Value, Recurring \| Level 2 \| U.S. government agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Total short-term investments	7,841
Fair Value, Recurring \| Level 2 \| Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Total short-term investments	5,360
Fair Value, Recurring \| Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Total cash equivalents	29,239	86,505
Fair Value, Recurring \| Money market funds \| Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Total cash equivalents	29,239	86,505
Fair Value, Recurring \| Money market funds \| Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Total cash equivalents	0	$ 0
Fair Value, Recurring \| Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Total cash equivalents	1,122
Fair Value, Recurring \| Corporate debt securities \| Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Total cash equivalents	0
Fair Value, Recurring \| Corporate debt securities \| Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Total cash equivalents	$ 1,122

Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jan. 31, 2022
Prepaid Expense and Other Current Assets
Prepaid expenses	$ 4,140	$ 4,518
Prepaid software	2,560	2,297
Other current assets	1,534	1,744
Total prepaid expenses and other current assets	$ 8,234	$ 8,559

Balance Sheet Components - Schedule of Property and Equipment, Net (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jan. 31, 2022
Property, Plant and Equipment
Total gross property and equipment	$ 17,096	$ 11,477
Accumulated depreciation and amortization	(9,666)	(7,189)
Total property and equipment, net	7,430	4,288
Computer equipment
Property, Plant and Equipment
Total gross property and equipment	3,586	3,711
Furniture and fixtures
Property, Plant and Equipment
Total gross property and equipment	342	412
Capitalized internal-use software
Property, Plant and Equipment
Total gross property and equipment	7,884	5,772
Leasehold improvements
Property, Plant and Equipment
Total gross property and equipment	1,889	1,582
Construction in progress—capitalized internal-use software
Property, Plant and Equipment
Total gross property and equipment	$ 3,395	$ 0

Balance Sheet Components - Additional Information of Property and Equipment Net (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Property, Plant and Equipment
Depreciation and amortization	$ 3,171	$ 2,824	$ 2,006
Capitalized internal-use software
Property, Plant and Equipment
Depreciation and amortization	$ 2,200	$ 1,900	$ 1,100

Balance Sheet Components - Schedule of Accrued Compensation and Benefits (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jan. 31, 2022
Accrued Compensation and Benefits
Accrued bonus	$ 5,944	$ 5,557
Accrued commissions	3,593	4,226
Accrued payroll and benefits	1,995	2,863
Employee contributions under the ESPP	1,109	3,497
Total accrued compensation and benefits	$ 12,641	$ 16,143

Balance Sheet Components - Schedule of Other Accrued Liabilities (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jan. 31, 2022
Other Accrued Liabilities
Accrued professional fees	$ 1,020	$ 717
Sales and value added tax payable	737	671
Income taxes payable	743	414
Accrued restructuring	1,567	0
Other	2,009	1,429
Total other accrued liabilities	$ 6,076	$ 3,231

Deferred Revenue and Remaining Performance Obligations - Schedule of Deferred Revenue Balances (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Contract with Customer, Liability
Deferred revenue	$ 71,716	$ 69,010
Deferred revenue, noncurrent	3,275	2,713
Total deferred revenue	$ 74,991	$ 71,723	$ 61,710

Deferred Revenue and Remaining Performance Obligations - Schedule of Changes In Deferred Revenue Balances (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022
Change In Contract With Customer Liability
Beginning balance	$ 71,723	$ 61,710
Performance obligations satisfied during the period that were included in the deferred revenue balance at the beginning of the year	(66,480)	(57,809)
Increases due to invoicing prior to satisfaction of performance obligations	69,748	67,822
Ending balance	$ 74,991	$ 71,723

Deferred Revenue and Remaining Performance Obligations - Additional Information (Details) $ in Millions	Jan. 31, 2023 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction
Remaining performance obligation	$ 165.9
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-02-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction
Remaining performance obligation	$ 117.2
Revenue expected to be recognized from remaining performance obligations, period	12 months

Debt - Additional Information (Details) - USD ($)	1 Months Ended		12 Months Ended
Debt - Additional Information (Details) - USD ($)	Jan. 31, 2021	Nov. 30, 2017	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021	Jun. 30, 2020	Apr. 30, 2019	Nov. 30, 2018
Debt Instrument
Interest expense, debt			$ (101,000)	$ (656,000)	$ (6,970,000)
Effective interest rate (as a percent)				4.10%	16.00%
Fair value of common stock							$ 400,000
Credit Facility
Debt Instrument
Maximum borrowing capacity	$ 40,000,000	$ 10,000,000			$ 40,000,000		$ 10,000,000	$ 15,000,000
Borrowed line of credit	$ 25,000,000
Fee payable on unused portion of line of credit (as a percent)	0.25%
Line of credit facility adjusted quick ratio	1.15
Repayment of outstanding principal amount				$ 25,000,000
Current borrowing capacity			$ 40,000,000
Credit Facility \| Minimum
Debt Instrument
Line of credit facility termination fee (as a percent)	0.50%
Credit Facility \| Maximum
Debt Instrument
Line of credit facility termination fee (as a percent)	1.00%
Credit Facility \| Prime Rate
Debt Instrument
Variable rate (as a percent)	0.50%	0.50%
Amended Loan \| Loans Payable
Debt Instrument
Maximum borrowing capacity						$ 25,000,000
Warrants issued to purchase common stock (in shares)							105,350
Exercise price of warrants or rights (in dollars per share)							$ 7.48
Warrants exercisable period (in years)							10 years

Leases - Narrative (Details) $ in Millions	12 Months Ended
Leases - Narrative (Details) $ in Millions	Jan. 31, 2023 USD ($)
Lessee, Lease, Description
Operating lease cost	$ 2.9
Variable lease cost	0.8
Short-term lease cost	$ 0.3
Maximum
Lessee, Lease, Description
Lease term (up to) (in years)	3 years

Leases - Schedule of Supplemental Cash Flow Related to Leases (Details) $ in Thousands	12 Months Ended
	Jan. 31, 2023 USD ($)
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash outflows from operating leases	$ 3,169
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$ 2,811

Leases - Schedule of Supplemental Balance Sheet Information (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Feb. 01, 2022	Jan. 31, 2022
Operating Lease, Assets And Liabilities, Lessee [Abstract]
Operating lease right-of-use assets	$ 6,940	$ 6,700	$ 0
Operating lease liabilities	3,117		0
Operating lease liabilities, noncurrent	4,543		$ 0
Total operating lease liabilities	$ 7,660	$ 7,500
Weighted-average remaining lease term (term)	2 years 8 months 12 days
Weighted-average discount rate (percent)	3.80%

Leases - Schedule of Operating Lease Maturities (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Feb. 01, 2022
Operating Leases
Fiscal 2024	$ 3,309
Fiscal 2025	2,975
Fiscal 2026	1,172
Fiscal 2027	352
Fiscal 2028 and thereafter	251
Total lease payments	8,059
Less: imputed interest	(399)
Operating lease, liability	$ 7,660	$ 7,500

Leases - Schedule of Future Minimum Rental Payments for Operating Leases (Details) $ in Thousands	Jan. 31, 2022 USD ($)
Minimum Annual Commitments
2023	$ 2,845
2024	2,638
2025	2,178
2026	362
2027 and thereafter	0
Total	$ 8,023

Commitments and Contingencies - Future Minimum Payments Non-cancelable Purchase Commitments (Details) $ in Thousands	Jan. 31, 2023 USD ($)
Minimum Annual Commitments
2024	$ 13,358
2025	15,141
2026	16,881
2027	14,167
2028 and thereafter	15,084
Total	$ 74,631

Stockholders’ Equity (Deficit) and Employee Incentive Plans - Additional Information (Details) $ / shares in Units, $ in Thousands				1 Months Ended	12 Months Ended
	Mar. 21, 2022 period	Jul. 26, 2021 USD ($) $ / shares shares	Jan. 31, 2018 shares	Jul. 31, 2021 participant shares	Jan. 31, 2023 USD ($) vote $ / shares shares	Jan. 31, 2022 USD ($) $ / shares shares	Jan. 31, 2021 USD ($) $ / shares	Jan. 12, 2023 shares
Share-based Compensation Arrangement by Share-based Payment Award
Conversion of convertible securities (in shares)				26,710,600,000,000
Preferred stock, shares authorized (in shares)					200,000,000	200,000,000
Preferred stock, par value (in dollars per share) \| $ / shares					$ 0.00001	$ 0.00001
Common stock, shares authorized (in shares)					1,000,000,000	1,000,000,000
Common stock, par value (in dollars per share) \| $ / shares					$ 0.00001	$ 0.00001
Number of vote \| vote					1
Dividend declared (in dollars per share) \| $ / shares					$ 0	$ 0
Number of shares reserved common stock for future issuance (in shares)					16,745,687	14,399,384
Initial offering period duration					24 months
Initial offering number of purchase periods \| period	4
Total stock-based compensation expense \| $					$ 25,786	$ 10,750	$ 4,671
Stock-based compensation, net of amounts capitalized \| $					$ 25,786	$ 10,750	4,671
Stock options outstanding
Share-based Compensation Arrangement by Share-based Payment Award
Number of shares reserved common stock for future issuance (in shares)					7,819,480	9,167,495
Total stock-based compensation expense \| $					$ 6,400	$ 7,500	$ 4,700
Unrecognized stock-based compensation expense related to unvested stock options \| $					$ 8,800
Stock-based compensation expected to be recognized weighted-average period (in years)					1 year 8 months 12 days
Options granted (in shares)					0
Option granted weighted-average grant-date fair value (in dollar per share) \| $ / shares						$ 9.30	$ 3.18
Aggregate intrinsic value of options exercised \| $					$ 9,300	$ 28,200	$ 3,600
Issuance of common stock upon exercise of stock, Shares					801,079
Stock options outstanding \| Third Party
Share-based Compensation Arrangement by Share-based Payment Award
Options granted (in shares)			40,646
Issuance of common stock upon exercise of stock, Shares					16,674
Cumulative shares exercised (in shares)					40,646
Service-Based Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award
Total stock-based compensation expense \| $					$ 15,300	1,100
Stock-based compensation expected to be recognized weighted-average period (in years)					3 years 2 months 12 days
Award requisite service period (in years)					4 years
Aggregate fair value of RSU granted \| $					$ 77,200	13,500
Unrecognized stock-based compensation expense related to service vesting-based RSUs \| $					$ 56,900
Market-Based Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award
Stock-based compensation expected to be recognized weighted-average period (in years)					2 years 8 months 12 days
Aggregate fair value of RSU granted \| $					$ 100	$ 7,900
Stock-based compensation, net of amounts capitalized \| $					2,000
Unrecognized stock-based compensation expense related to service vesting-based RSUs \| $					$ 4,900
2021 Plan
Share-based Compensation Arrangement by Share-based Payment Award
Share-based compensation granted expiration period (in years)					10 years
Share-based compensation vesting period (in years)					4 years
Share-based compensation available for grant (in shares)					2,100,000
Number of shares reserved common stock for future issuance (in shares)					4,120,000
Share-based compensation percentage of outstanding stock (as a percent)					5.00%
2021 Plan \| First Anniversary
Share-based Compensation Arrangement by Share-based Payment Award
Share-based compensation vesting rights (as a percent)					25.00%
2021 Plan \| Second Anniversary
Share-based Compensation Arrangement by Share-based Payment Award
Share-based compensation vesting rights (as a percent)					2.08%
2023 Plan
Share-based Compensation Arrangement by Share-based Payment Award
Number of shares authorized (in shares)								1,300,000
Employee stock purchase rights under the ESPP
Share-based Compensation Arrangement by Share-based Payment Award
Employee maximum contribution (as a percent)				15.00%
Discount rate on market value of share, percentage				85.00%
Number of participant may purchase more than 1000 shares \| participant				0
Total stock-based compensation expense \| $					$ 2,000
Employee contributions under the ESPP \| $					1,100
Unrecognized stock-based compensation expense related to unvested stock options \| $					$ 700
Stock-based compensation expected to be recognized weighted-average period (in years)					7 months 6 days
Share purchases related to ESPP (in shares)					314,315
IPO
Share-based Compensation Arrangement by Share-based Payment Award
Conversion of convertible securities (in shares)		26,710,600
Additional redeemable convertible preferred stock converted into shares of common stock		640,387
Number of shares outstanding (in shares)					0
Number of common stock for sale and issuance (in shares)				9,589,999,000,000	0
Preferred stock, shares authorized (in shares)		200,000,000
Preferred stock, par value (in dollars per share) \| $ / shares		$ 0.00001
IPO \| Series E
Share-based Compensation Arrangement by Share-based Payment Award
Additional redeemable convertible preferred stock converted into shares of common stock		162,032
Redeemable convertible preferred stock carrying amount \| $		$ 259,800
IPO \| Series G
Share-based Compensation Arrangement by Share-based Payment Award
Additional redeemable convertible preferred stock converted into shares of common stock		478,355

Stockholders’ Equity (Deficit) and Employee Incentive Plans - Summary of Reserved Common Stock for Future Issuance (Details) - shares	Jan. 31, 2023	Jan. 31, 2022
Class of Stock
Number of shares reserved common stock for future issuance (in shares)	16,745,687	14,399,384
2021 Plan
Class of Stock
Number of shares reserved common stock for future issuance (in shares)	4,120,000
Stock options outstanding
Class of Stock
Number of shares reserved common stock for future issuance (in shares)	7,819,480	9,167,495
Restricted stock units issued and outstanding
Class of Stock
Number of shares reserved common stock for future issuance (in shares)	4,502,982	1,497,558
Shares available for future issuance under the 2023 Inducement Plan \| 2021 Plan
Class of Stock
Number of shares reserved common stock for future issuance (in shares)	2,063,716	2,798,981
Shares available for future issuance under the 2023 Inducement Plan \| 2023 Plan
Class of Stock
Number of shares reserved common stock for future issuance (in shares)	1,300,000	0
ESPP
Class of Stock
Number of shares reserved common stock for future issuance (in shares)	954,159	830,000
Common stock warrants
Class of Stock
Number of shares reserved common stock for future issuance (in shares)	105,350	105,350

Stockholders' Equity (Deficit) and Employee Incentive Plans - Summary of Stock Option Activity under Stock Plans (Details) - Stock options outstanding - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022
Options Outstanding, Number of Options
Beginning balance (in shares)	9,150,821
Options exercised (in shares)	(801,079)
Options granted (in shares)	0
Options cancelled (in shares)	(530,262)
Ending balance (in shares)	7,819,480	9,150,821
Options vested and expected to vest as of January 31, 2022 (in shares)	7,819,480
Options vested and exercisable as of January 31, 2022 (in shares)	6,525,570
Options Outstanding, Weighted Average Exercise Price
Beginning balance (in dollars per share)	$ 9.76
Options exercised (in dollars per share)	6.40
Options granted (in dollars per share)	0
Options cancelled (in dollars per share)	14.54
Ending balance (in dollars per share)	9.78	$ 9.76
Options vested and expected to vest as of January 31, 2022 (in dollars per share)	9.78
Options vested and exercisable as of January 31, 2022 (in dollars per share)	$ 8.27
Stock Options Additional Disclosures
Options outstanding, weighted average remaining contractual term (in years)	5 years 2 months 15 days	6 years 6 months 10 days
Options vested and expected to vest, weighted-average contractual term (in years)	5 years 2 months 15 days
Options vested and exercisable, weighted-average contractual term (in years)	4 years 8 months 8 days
Options outstanding, aggregate intrinsic value	$ 51,606	$ 126,368
Options vested and expected to vest, aggregate intrinsic value	51,606
Options vested and exercisable, aggregate intrinsic value	$ 48,560

Stockholders' Equity (Deficit) and Employee Incentive Plans - Summary of RSU Activity (Details)	12 Months Ended
	Jan. 31, 2023 $ / shares shares
RSUs Outstanding, Number of RSUs
Ending balance (in shares) \| shares	3,442,982
RSUs Outstanding, Weighted Average Grant Date Fair Value Per Share
Ending balance (in dollars per share) \| $ / shares	$ 18.39
Service-Based Restricted Stock Units (RSUs)
RSUs Outstanding, Number of RSUs
Beginning balance (in shares) \| shares	283,558
Market based RSUs granted (in shares) \| shares	4,340,172
RSUs vested (in shares) \| shares	(452,477)
RSUs forfeited (in shares) \| shares	(728,271)
RSUs Outstanding, Weighted Average Grant Date Fair Value Per Share
Beginning balance (in dollars per share) \| $ / shares	$ 43.76
RSUs granted (in dollars per share) \| $ / shares	17.80
RSUs vested (in dollars per share) \| $ / shares	23.07
RSUs forfeited (in dollars per share) \| $ / shares	$ 21.84
Market-Based Restricted Stock Units (RSUs)
RSUs Outstanding, Number of RSUs
Beginning balance (in shares) \| shares	1,214,000
Market based RSUs granted (in shares) \| shares	14,000
RSUs vested (in shares) \| shares	0
RSUs forfeited (in shares) \| shares	(168,000)
Ending balance (in shares) \| shares	1,060,000
RSUs Outstanding, Weighted Average Grant Date Fair Value Per Share
Beginning balance (in dollars per share) \| $ / shares	$ 6.48
RSUs granted (in dollars per share) \| $ / shares	5.30
RSUs vested (in dollars per share) \| $ / shares	0
RSUs forfeited (in dollars per share) \| $ / shares	6.48
Ending balance (in dollars per share) \| $ / shares	$ 6.47

Stockholders' Equity (Deficit) and Employee Incentive Plans - Schedule of Share-based Payment Award, Restricted Stock Units, Valuation Assumptions (Details) - Market-Based Restricted Stock Units (RSUs)	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award
Expected term (in years)	4 years 8 months 12 days	5 years
Expected volatility	63.00%	50.00%
Risk-free interest rate	2.90%	1.70%
Dividend yield	0.00%	0.00%

Stockholders' Equity (Deficit) and Employee Incentive Plans - Summary of Fair Value of Employee Stock Options Estimated using Weighted-average Assumptions (Details) - Stock options outstanding	12 Months Ended
	Jan. 31, 2022	Jan. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award
Expected term (in years)	6 years 1 month 6 days	6 years 1 month 6 days
Expected volatility	42.00%	40.00%
Risk-free interest rate	1.00%	0.40%
Dividend yield	0.00%	0.00%

Stockholders' Equity (Deficit) and Employee Incentive Plans - Summary of Weighted-Average Assumptions Used In Estimating Fair Value of Employee Stock Purchase Rights (Details) - Stock options outstanding	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award
Expected term (in years)		6 years 1 month 6 days	6 years 1 month 6 days
Expected volatility		42.00%	40.00%
Risk-free interest rate		1.00%	0.40%
Dividend yield		0.00%	0.00%
Employee stock purchase rights under the ESPP
Share-based Compensation Arrangement by Share-based Payment Award
Expected term (in years)	10 months 24 days	1 year
Expected volatility	63.00%	50.00%
Risk-free interest rate	0.60%	0.10%
Dividend yield	0.00%	0.00%

Stockholders' Equity (Deficit) and Employee Incentive Plans - Summary of Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Share-based Payment Arrangement, Expensed and Capitalized, Amount
Recognized stock-based compensation expense	$ 25,786	$ 10,750	$ 4,671
Research and development
Share-based Payment Arrangement, Expensed and Capitalized, Amount
Recognized stock-based compensation expense	7,937	3,343	1,316
Sales and marketing
Share-based Payment Arrangement, Expensed and Capitalized, Amount
Recognized stock-based compensation expense	9,426	3,968	1,536
General and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount
Recognized stock-based compensation expense	7,390	3,047	1,696
Restructuring
Share-based Payment Arrangement, Expensed and Capitalized, Amount
Recognized stock-based compensation expense	65	0	0
Cost of revenue - subscription \| Cost of revenue
Share-based Payment Arrangement, Expensed and Capitalized, Amount
Recognized stock-based compensation expense	535	196	69
Cost of revenue - services \| Cost of revenue
Share-based Payment Arrangement, Expensed and Capitalized, Amount
Recognized stock-based compensation expense	$ 433	$ 196	$ 54

Income Taxes - Components of Income Before Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Income (Loss) from Continuing Operations
United States	$ (75,449)	$ (61,180)	$ (42,232)
International	7,993	3,966	3,293
Loss before income taxes	$ (67,456)	$ (57,214)	$ (38,939)

- Definition

Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 940
-SubTopic 20
-Section 25
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(10))
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(8))
-URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 235
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-URI https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(15))
-URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

+ Details

Income Taxes - Components of Income Tax Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Current
Federal	$ 0	$ 0	$ 0
State	65	58	53
Foreign	1,459	957	991
Current tax expense	1,524	1,015	1,044
Deferred
Federal	0	0	0
State	0	0	0
Foreign	(486)	0	0
Deferred income tax benefit	(486)	0	0
Total provision for income taxes	$ 1,038	$ 1,015	$ 1,044

Income Taxes - Effective Income Tax Rate Reconciliation (Details)	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Effective Income Tax Rate Reconciliation, Percent [Abstract]
Provision for income taxes computed at federal statutory rate	21.00%	21.00%	21.00%
State taxes, net of federal benefits	4.80%	5.00%	13.70%
Foreign rate differential	1.60%	0.20%	(0.30%)
Stock-based compensation	(2.60%)	2.00%	0.10%
Tax credits	2.20%	2.20%	(0.10%)
U.S. tax on foreign earnings	(1.40%)	(0.20%)	1.10%
Change in valuation allowance	(24.20%)	(31.20%)	(37.80%)
Other	(2.90%)	(0.80%)	(0.40%)
Total	(1.50%)	(1.80%)	(2.70%)

Income Taxes - Components of Deferred Tax Assets (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Deferred tax assets:
Net operating loss carryforwards	$ 82,366	$ 80,434
Tax credit carryforwards	15,927	13,311
Accruals and reserves	4,076	2,541
Interest carryforwards	2,344	2,873
Deferred revenue	36	776
Stock-based compensation	3,302	2,680
Capitalized research & development costs	16,352	3,882
Other	32	6
Gross deferred tax assets	124,435	106,503
Less: Valuation allowance	(117,310)	(100,983)	$ (83,100)
Total deferred tax assets	7,125	5,520
Deferred tax liabilities:
Deferred commissions	(4,993)	(4,858)
Other	(1,646)	(662)
Total deferred tax liabilities	(6,639)	(5,520)
Net deferred tax assets (liabilities)	$ 486	$ 0

Income Taxes - Additional Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Operating Loss Carryforwards
Valuation allowance	$ 117,310	$ 100,983	$ 83,100
Change in deferred valuation allowance	16,300	$ 17,900	$ 14,700
Operating loss carryforward, federal	324,400
Operating loss carryforward, state and local	178,500
Operating loss carryforwards, not subject to expiration	$ 155,600
Taxable income utilization limit, percentage	80.00%
Operating loss carryforwards, subject to expiration	$ 168,800
Federal \| Research
Operating Loss Carryforwards
Tax credit carryforward	13,800
State \| Research
Operating Loss Carryforwards
Tax credit carryforward	$ 12,600

Income Taxes - Unrecognized Tax Benefits (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns
Beginning balance	$ 8,835	$ 7,162	$ 3,601
Increase related to current year tax positions	1,744	1,673	1,401
Increase related to prior year tax positions	0	0	2,160
Ending balance	$ 10,579	$ 8,835	$ 7,162

Restructuring - Schedule of Restructuring Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Restructuring Cost and Reserve
Total restructuring charges	$ 1,663	$ 0	$ 0
Employee severance and related costs
Restructuring Cost and Reserve
Total restructuring charges	1,598
Stock-based compensation
Restructuring Cost and Reserve
Total restructuring charges	$ 65

Restructuring - Additional Information (Details) - USD ($)	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022
Restructuring Cost and Reserve
Restructuring liabilities	$ 1,567,000	$ 0
Payments for Restructuring	0
Employee severance and related costs
Restructuring Cost and Reserve
Restructuring liabilities	$ 1,600,000

Geographic Information - Schedule of Disaggregation of Revenue by Geographic Area (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Segment Reporting Information
Total revenue	$ 154,824	$ 123,542	$ 103,285
United States
Segment Reporting Information
Total revenue	95,762	77,074	66,737
International
Segment Reporting Information
Total revenue	$ 59,062	$ 46,468	$ 36,548

- Definition

Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 924
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-URI https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856

+ Details

Net Loss per Share - Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Numerator
Net loss	$ (68,494)	$ (58,229)	$ (39,983)
Cumulative dividends on Series G redeemable convertible preferred stock	0	(2,917)	(4,076)
Net loss attributable to common stockholders	(68,494)	(61,146)	(44,059)
Net loss attributable to common stockholders	$ (68,494)	$ (61,146)	$ (44,059)
Denominator
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)	44,787,000	25,777,000	5,717,000
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)	44,787,000	25,777,000	5,717,000
Net loss per share attributable to common stockholders, basic (in shares)	$ (1.53)	$ (2.37)	$ (7.71)
Net loss per share attributable to common stockholders, diluted (in shares)	$ (1.53)	$ (2.37)	$ (7.71)

Net Loss per Share - Schedule of Potentially Dilutive Securities Were Excluded From The Computation of Diluted Net Loss Per Share (Details) - shares shares in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities were excluded from computation of diluted net loss per share (in shares)	12,553	11,001	35,530
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities were excluded from computation of diluted net loss per share (in shares)	7,819	9,167	8,912
RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities were excluded from computation of diluted net loss per share (in shares)	4,499	1,498	0
Employee stock purchase rights under the ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities were excluded from computation of diluted net loss per share (in shares)	130	231	0
Common stock warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities were excluded from computation of diluted net loss per share (in shares)	105	105	105
Redeemable convertible preferred stock (on an if-converted basis)
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities were excluded from computation of diluted net loss per share (in shares)	0	0	26,513

Subsequent Events (Details) - USD ($) $ in Millions		12 Months Ended
Subsequent Events (Details) - USD ($) $ in Millions	Mar. 20, 2023	Jan. 31, 2023
Market-Based Restricted Stock Units (RSUs)
Subsequent Event
RSUs granted (in shares)		14,000
Subsequent Event \| Market-Based Restricted Stock Units (RSUs) \| Executive Officers
Subsequent Event
RSUs granted (in shares)	1,060,000
Subsequent Event \| Performance-Based Restricted Stock Units (RSUs) \| Executive Officers
Subsequent Event
RSUs granted (in shares)	840,000
Share based compensation not yet recognized	$ 6.0
Subsequent Event \| Performance-Based Restricted Stock Units (RSUs) \| Senior Management
Subsequent Event
RSUs granted (in shares)	220,000
Share based compensation not yet recognized	$ 1.4